Veterinary Drug terms | HESTIA Glossary

Browse all 1,061 veterinary drug terms HESTIA uses to describe agricultural data — with definitions and synonyms. Free and open.

(-)-Epigallocatechin gallate 3,4,5-Trihydroxybenzoic acid (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester; Epigallocatechin gallate; CCRIS 3729
(2,6-Dimethylphenoxy)acetic acid 2,6-Dimethylphenoxy acetic acid; (2,6-Dimethylphenoxy)acetic acid; (2,6-Dimethylphenoxy)acetic acid
(2S,3S,4R,5R,6R)-5-[(2S,3R,4R,5S,6R)-3-Acetamido-5-[(2S,3R,4R,5S)-3-acetamido-4-hydroxy-6-methyl-5-[(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-[(2-hydroxy-5-oxocyclopenten-1-yl)carbamoyl]oxan-2-yl]oxyoxan-2-yl]oxy-4-hydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-4-carbamoyloxy-6-[[(2R)-2-carboxy-2-[(2E,6E,13E)-3,8,8,14,18-pentamethyl-11-methylidenenonadeca-2,6,13,17-tetraenoxy]ethoxy]-hydroxyphosphoryl]oxy-3-hydroxy-3-methyloxane-2-carboxylic acid Flavomycin; Flavomycin; 11015-37-5; C69H107N4O35P; MFCD01742468; AKOS016339637; KS-5173; I020; 015F375; Flavomycin; CHEBI:28908; AKOS015896369; C06765; 11015-37-5; Moenomycin complex; SCHEMBL49283; UNII-2RO799DN06; I06-1954; 2RO799DN06; J-002385; Q27103953; Flavomycin; 11015-37-5; Bambermycins; Bambermicina [INN-Spanish]
(3S,6S,9R,12R,15S,18S,21R,24R,27S,30S,36R)-6,18,30-Trimethyl-3,9,12,15,21,24,27,33,36-nona(propan-2-yl)-1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexazacyclohexatriacontane-2,5,8,11,14,17,20,23,26,29,32,35-dodecone Valinomycin; valinomycin; Potassium ionophore I; valino; UNII-N561YS75MN; Valinomicin; 2001-95-8; CHEBI:28545; N561YS75MN; NSC122023; Antibiotic N-329 B; cyclo[-D-O-Val-D-Val-L-O-Ala-L-Val]3; Cyclic(D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl); HSDB 6423; EINECS 217-896-6; NSC 122023; BRN 0078657; (3R,6R,9S,12S,15R,18R,21S,24S,27R,30R,33S,36S)-3,6,9,15,18,21,27,30,33-nonaisopropyl-12,24,36-trimethyl-1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane-2,5,8,11,14,17,20,23,26,29,32,35-dodecone; Potassium ionophore I - cocktail B, Selectophore(TM); balinomycin; 1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane- 2,5,8,11,14,17,20,23,26,29,32,35-dodecone, 12,24,36-trimetyl-3,6,9,15,18,21,27,30,33-nonakis(1-methylethyl)-; 4-27-00-09728 (Beilstein Handbook Reference); CHEMBL223643; HY-N6693; BDBM50237619; AKOS024457589; CCG-208283; DB14057; CS-0029275; Q417504; SR-05000002323; SR-05000002323-2; (3R,6R,9S,12S,15R,18R,21S,24S,27R,30R,33S,36S)-3,6,9,15,18,21,27,30,33-nonaisopropyl-12,24,36-trimethyl-1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexazacyclohexatriacontane-2,5,8,11,14,17,20,23,26,29,32,35-dodecone; Cyclic(D-.alpha.-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-.alpha.-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-.alpha.-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl ); Cyclo(D-?-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-?-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-?-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl); valinomycin; 2001-95-8; C54H90N6O18; 2095AH; MFCD00005114; QTL1_000089; BP-30215; C06684; 001V958; Cyclo(L-Val-D-HyIva-D-Val-L-Lac-)3: HyIva = alpha-Hydroxyisovaleric acid, Lac = Lactic acid; valinomycin; Valinomicin; GNF-Pf-5297; Antibiotic N-329 B; 2001-95-8; 6,18,30-trimethyl-3,9,12,15,21,24,27,33,36-nona(propan-2-yl)-1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexazacyclohexatriacontane-2,5,8,11,14,17,20,23,26,29,32,35-dodecone; HSDB 6423; C54H90N6O18; EINECS 217-896-6; NSC 122023; BRN 0078657; 1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane- 2,5,8,11,14,17,20,23,26,29,32,35-dodecone, 12,24,36-trimetyl-3,6,9,15,18,21,27,30,33-nonakis(1-methylethyl)-; Valinomycin, Streptomyces fulvissimus; (+)-VALINOMYCIN; SCHEMBL41016; BSPBio_001226; KBioGR_000566; KBioGR_002478; KBioSS_000566; KBioSS_002485; CHEMBL602575; CHEBI:95123; KBio2_000566; KBio2_002478; KBio2_003134; KBio2_005046; KBio2_005702; KBio2_007614; KBio3_001011; KBio3_001012; KBio3_002956; cMAP_000062; FCFNRCROJUBPLU-UHFFFAOYSA-N; Bio1_000384; Bio1_000873; Bio1_001362; Bio2_000453; Bio2_000933; HMS1362N07; HMS1792N07; HMS1990N07; HMS3403N07; BDBM50420225; AKOS024319642; MCULE-3030978952; NSC-122023; IDI1_002208; NCGC00095987-01; NCGC00095987-02; NCGC00095987-03; LS-161344; FT-0675766; J-012948; Q27166904; 1,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane-2,5,8,11,14,17,20,23,26,29,32,35-dodecone, 12,24,36-trimethyl-3,6,9,15,18,21,27,30,33-nonakis(1-methylethyl)-; 1,7,13,19,25,31-Hexaaza-4,10,16,22,28,34-hexaoxa-6,9,12,18,21,24,30,33,36-nonaisopropyl-3,15,27-trimethylcyclohexatriacontane-2,5,8,11,14,17,20,23,26,29,32,35-dodecone; Cyclo(D-.alpha.-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-.alpha.-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-.alpha.-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl); WLN: T-36-MV DOV GMV JOV MMV POV SMV VOV B&MV E&OV H&MV K&OVTJ CY1&1 FY1&1I1 LY1&1 OY1&1 RY1&1 U1 A&Y1&1 D&Y1&1 G&Y1&1 J&1 M&Y1&1; valinomycin; valinomycin; BSPBio_002388; SPECTRUM1505107; CCG-214534; NCGC00178679-01; NCGC00178679-02; valinomycin; valinomycin; 2001-95-8; B7388; Valinomycin, 98%; valinomycin; 2001-95-8; 4-27-00-09728 (Beilstein Handbook Reference)
(E)-Crotonaldehyde (E)-2-Butenal; CROTONALDEHYDE; 2-Butenal; Crotylaldehyde; Crotonal; (2E)-but-2-enal; trans-Crotonaldehyde; (E)-Crotonaldehyde; 123-73-9; Crotonic aldehyde; (E)-but-2-enal; Methylpropenal; trans-2-Butenal; Propylene aldehyde; 1-Formylpropene; beta-Methylacrolein; 2-Butenal, (2E)-; 4170-30-3; Aldehyde crotonique; 2-Butenaldehyde; trans-but-2-enal; but-2-enal; Topanel; trans-2-butenaldehyde; trans- Crotonal; 2-Butenal, (E)-; Topanel CA; RCRA waste number U053; E-2-Butenal; beta-Methyl acrolein; (E)-2-Butenal; Krotonaldehyd [Czech]; CROTONALDEHYDE, (E)-; Krotonaldehyd; NSC 56354; Aldehyde crotonique [French]; CCRIS 909; (E)-Crotonaldehyde (IUPAC); UN 1143; CCRIS 4501; Crotonaldehyde, cis-; HSDB 252; (2E)-crotonaldehyde; 2-Butenal, inhibited; UNII-6PUW625907; CHEBI:41607; HSDB 2871; NCI-C56279; Crotonaldehyde, inhibited; AI3-18303 (USDA); EINECS 204-647-1; EINECS 224-030-0; UN1143; RCRA waste no. U053; 3-Methylacrolein, inhibited; AI3-18303; CHEMBL1086445; MLUCVPSAIODCQM-NSCUHMNNSA-N; 6PUW625907; Crotonaldehyde, 99+%; .beta.-Methylacrolein; Croton aldehyde; 15798-64-8; 2-Buten-1-al; Crotonaldehyde, stabilized [UN1143] [Poison]; Crotonaldehyde, stabilized; Epitope ID:143635; EC 224-030-0; InChI=1/C4H6O/c1-2-3-4-5/h2-4H,1H3/b3-2; GTPL6288; DTXSID6020351; STR00019; ZINC1686876; 7212AF; BBL011428; BDBM50318489; LS-113; MFCD00007003; STL146535; Crotonaldehyde, 99+%, AcroSeal(R); AKOS005720774; BBV-266436; DB04381; FCH3460384; FCH4685679; LS-7290; RTR-003714; NCGC00090830-01; NCGC00090830-02; Crotonaldehyde, predominantly trans, 98%; SC-48719; SC-79921; BB0294983; TR-003714; CS-0015768; FT-0611626; EN300-19159; C19377; Crotonaldehyde, stabilized [UN1143] [Poison]; A805141; Q416036; F2191-0167; UNII-9G72074TUW component MLUCVPSAIODCQM-NSCUHMNNSA-N; Crotonaldehyde, mixture of cis and trans, purum, ratio of cis- and trans-isomers (~1:20), >=98.0% (GC); Crotonaldehyde, mixture of cis and trans, ratio of cis- and trans-isomers (~1:20), >=99.5% (GC); Crotonaldehyde, predominantly trans, >=99%, contains 0.1-0.2% BHT as stabilizer, 1% H2O as stabilizer; (E)-Crotonaldehyde; trans- Crotonal
(R)-(+)-Atenolol 4-[(2R)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide; Atenolol, (+)-; (R)-Atenolol
(R)-4-Amino-3-isoxazolidinone D-cycloserine; cycloserine; 68-41-7; Seromycin; orientomycin; Oxamycin; Cyclo-D-serine; Cyclorin; D-4-amino-3-isoxazolidinone; Cicloserina; Farmiserina; Miroseryn; Tisomycin; Wasserina; Closina; D-4-amino-3-isoxazolidone; alpha-Cycloserine; (R)-4-AMINOISOXAZOLIDIN-3-ONE; (+)-4-Amino-3-isoxazolidinone; Cycloserinum; Miroserina; Tebemicina; Novoserin; (+)-Cycloserine; Oxamicina; D-(+)-Cycloserine; (4R)-4-aminoisoxazolidin-3-one; PA 94; (4R)-4-amino-1,2-oxazolidin-3-one; Oxamicina [Italian]; Cycloserin; Micoserina; Cicloserina [Italian]; PA-94; (R)-4-AMINO-ISOXAZOLIDIN-3-ONE; D-Oxamycin; RO-1-9213; D-CS; Cycloserinum [INN-Latin]; E-733-A; Cicloserina [INN-Spanish]; D-4-Amino-3-isossazolidone; 3-Isoxazolidinone, 4-amino-, (R)-; (R)-4-Amino-3-isoxazolidinone; 3-Isoxazolidinone, 4-amino-, (4R)-; HSDB 3218; D-Oxamicina; 3-Isoxazolidinone, 4-amino-, d-; K-300; UNII-95IK5KI84Z; I-1431; 3-Isoxazolidinone, 4-amino-, (+)-; D-4-Amino-3-isossazolidone [Italian]; NSC 154851; CHEBI:40009; AI3-50153; D-Cycloserine, synthetic; EINECS 200-688-4; (R)-(+)-4-Amino-3-isoxazolidinone; CHEMBL771; BRN 0080798; SC-49088; 95IK5KI84Z; DCS; DYDCUQKUCUHJBH-UWTATZPHSA-N; MFCD00005353; CAS-68-41-7; NCGC00016306-01; D-Cycloserine, 98%; DSSTox_CID_2870; 3-Isoxazolidinone, 4-amino-, (+)- (8CI); DSSTox_RID_76766; DSSTox_GSID_22870; Cycloserine, D-; Closerin; .alpha.-Cycloserine; (R)-Cycloserine; Seromycin (TN); CPD000058313; SMR000058313; R-4-Amino-3-isoxazolidinone; Cycloserine [INN:BAN:JAN]; (S)-(-)-Cycloserine; R-(+)-Cycloserine; (4R)-4-Amino-3-isoxazolidinone; SR-01000075432; DRG-0195; (R)-(+)-Cycloserine; D-amino-3-isoxazolidinone; (R)-4-Amino-3-isoxazolidone; NSC-76029; Serine, cyclo-; NSC-154851; 3-Isoxazolidinone, 4-amino-, D; R(+)-4-Amino-3-isoxazolidinone; Cycloserine [USP:INN:BAN:JAN]; 4AX; 3-Isoxazolidinone, 4-amino-, (R); PubChem5763; D-Cycloserine, powder; Spectrum_000860; 1pb9; CYCLOSERINE (D); Prestwick0_001089; Prestwick1_001089; Prestwick2_001089; Prestwick3_001089; Spectrum2_000084; Spectrum3_000371; Spectrum4_000305; Spectrum5_000797; Lopac-C-1159; Lopac-C-3909; Lopac-C-7005; 3-Isoxazolidinone, 4-amino-, (4R)- (9CI); C 3909; C-9390; C-9400; Lopac0_000252; SCHEMBL34322; BSPBio_001138; BSPBio_002121; KBioGR_000890; KBioSS_001340; 4-27-00-05549 (Beilstein Handbook Reference); MLS000758215; MLS001423962; MLS002548887; BIDD:GT0707; D-Cycloserine synth. BP 88; DivK1c_000098; SPECTRUM1500215; SPBio_000008; SPBio_003029; BPBio1_001252; FA6C7F8B-D080-4EA3-978F-1ECFB5A29D09; GTPL9489; Cycloserine (JP17/USP/INN); 4-Amino-3-isoxazolidinone, D-; DTXSID8022870; HMS500E20; KBio1_000098; KBio2_001340; KBio2_003908; KBio2_006476; KBio3_001341; NINDS_000098; HMS1571I20; HMS1920C06; HMS2051C15; HMS2091I14; HMS2098I20; HMS2232F03; HMS3259L19; HMS3260D06; HMS3715I14; NJ-21; Pharmakon1600-01500215; (R)-3-Isoxazolidinone, 4-amino-; 4-Amino-3-isoxazolidinone, (R)-; ACT04767; HY-B0030; KS-00001FB7; Tox21_110361; Tox21_500252; BDBM50038178; BDBM50103516; CCG-39705; D-Cycloserine, >=96.0% (NT); LMPK14000007; NSC756712; s1998; ZINC34676245; 4-Isoxazolidinamine, 3-oxo-, (D)-; AKOS015994626; Tox21_110361_1; AC-4721; CS-2395; DB00260; HS-0079; LP00252; MCULE-4212827696; NC00050; NC00676; NSC-756712; SDCCGSBI-0050240.P005; IDI1_000098; SMP1_000167; NCGC00015213-01; NCGC00015213-02; NCGC00015213-03; NCGC00016306-02; NCGC00016306-03; NCGC00016306-04; NCGC00016306-05; NCGC00016306-07; NCGC00016306-08; NCGC00093713-01; NCGC00093713-02; NCGC00260937-01; BR-26256; CAS-339-72-0; K138; LS-86757; SAM001247014; SAM002264599; SC-06256; ST075697; SBI-0050240.P004; AB0007232; AB2000415; ST2408171; AB00443920; EU-0100252; FT-0624464; (4R)-4-amino-2,4,5-trihydroisoxazol-3-one; C08057; D00877; AB00443920_09; AB00443920_10; 005C353; 101039-EP2295402A2; 101039-EP2301544A1; Q418508; SR-01000759389; SR-01000075432-1; SR-01000075432-2; SR-01000075432-5; SR-01000075432-9; SR-01000759389-4; SR-01000075432-10; F2173-1228; Z1522567171; Cycloserine, United States Pharmacopeia (USP) Reference Standard; Cycloserine, Pharmaceutical Secondary Standard; Certified Reference Material; Cycloserine; E-733-A
(R)-Fluoxetine (gammaR)-N-Methyl-gamma-[4-(trifluoromethyl)phenoxy]benzenepropanamine; Fluoxetine, (R)-; UNII-F279341RUQ
(S)-3,5-Dihydroxyphenylglycine (alphaS)-alpha-Amino-3,5-dihydroxybenzeneacetic acid; Dihydroxyphenylglycine; UNII-CF5G2G268A
(S)-Warfarin 4-Hydroxy-3-[(1S)-3-oxo-1-phenylbutyl]-2H-1-benzopyran-2-one; (S)-Warfarin; 5543-57-7; S-WARFARIN; (-)-Warfarin; (S)-(-)-Warfarin; levrowarfarin; UNII-HP31W7FNP4; (S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one; HP31W7FNP4; (S)-4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone; CHEBI:87738; 4-HYDROXY-3-[(1S)-3-OXO-1-PHENYLBUTYL]-2H-CHROMEN-2-ONE; Warfarin, (S)-; s(-)-warfarin; EINECS 226-907-3; 1ha2; BIDD:PXR0197; SCHEMBL20806; SCHEMBL662875; CHEMBL251074; DTXSID50873382; PJVWKTKQMONHTI-HNNXBMFYSA-N; ZINC3875543; 1094AH; 2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-, (S)-; MFCD00272381; AKOS027320629; ZINC100006264; DB02507; DB14055; GS-6170; NCGC00165934-01; (S)-(-)-Warfarin, >=97% (HPLC); S-(-)-3-Acetonybenzyl)-4-hydroxycoumarin; FT-0635767; BIM-0061758.0001; C20129; A840201; C-19146; BRD-K25991148-001-01-7; Q27093493; UNII-5Q7ZVV76EI component PJVWKTKQMONHTI-HNNXBMFYSA-N; 2-hydroxy-3-[(1S)-3-oxo-1-phenylbutyl]-1-benzopyran-4-one; 2-hydroxy-3-[(1S)-3-oxo-1-phenylbutyl]-4H-chromen-4-one; 2-oxidanyl-3-[(1S)-3-oxidanylidene-1-phenyl-butyl]chromen-4-one; 4-hydroxy-3-[(1S)-3-oxo-1-phenylbutyl]-2H-1-benzopyran-2-one; S-(-)-4-Hydroxy-3-(3-oxo-1-phenybutyl)-2H-1-benzopyran-2-one; Warfarin, (S)-; EINECS 226-907-3
(SP-4-2)-Diamminedichloroplatinum cis-Platin; cis-DDP; Cisplatine; Cisplatino; Cisplatinum; Lederplatin; Briplatin; Cismaplat; Neoplatin; Platamine; Platinex; Randa; trans-platin; cis-Dichlorodiammineplatinum(II); Peyrone's salt; cis-Diamminedichloroplatinum; Peyrone's chloride; cis-[PtCl2(NH3)2]; CHEBI:27899; CHEBI:35852; trans-Platinum(II) diamminedichloride; trans-DDP, 8; Cisplatin, 1; Epitope ID:194799; Epitope ID:194800; BDBM92386; cis-diamminedichloridoplatinum(II); LXZZYRPGZAFOLE-UHFFFAOYSA-L; (SP-4-1)-diamminedichloroplatinum; (SP-4-2)-diamminedichloroplatinum; trans-diamminedichloridoplatinum(II); (SP-4-1)-diamminedichloridoplatinum; (SP-4-2)-diamminedichloridoplatinum; AKOS025117566; DB00515; EU-0100918; FT-0623940; cis-Diaminedichloroplatinum; cis Diamminedichloroplatinum
1,10-Phenanthroline 1,10-phenanthroline; o-phenanthroline; 66-71-7; Phenanthroline; 4,5-diazaphenanthrene; orthophenanthroline; 1,10-o-phenanthroline; 2-phenanthroline; beta-phenanthroline; 1,10-Phenanthroline anhydrous; phen; 1,10-Fenanthrolin; .beta.-Phenanthroline; [1,10]phenanthroline; 1,10-Fenanthrolin [Czech]; UNII-W4X6ZO7939; CCRIS 4855; 1,10-Phenanthroline, Anhydrous; C12H8N2; NSC 4265; EINECS 200-629-2; MFCD00011678; NSC 203545; MLS000069797; CHEMBL415879; CHEBI:44975; DGEZNRSVGBDHLK-UHFFFAOYSA-N; W4X6ZO7939; NSC203545; NSC4265; SMR000058190; DSSTox_CID_5857; pyridino[3,2-h]quinoline; DSSTox_RID_77950; DSSTox_GSID_25857; 1,10-Phenanthroline, 99+%; MLS002701886; CAS-66-71-7; PHN; Activ-8; copper phenanthroline; NSC-4265; O-PHE; phenantroline; (OP)2Cu(I); o-Phenanthrolin; Cyto5A5; 1,10-phenanthrolin; 1,10-phenantroline; 1,10-phenathroline; 1,10 phenanthroline; 1,10-Fenanthroline; 1.10-phenanthroline; 1,1 0-phenanthroline; ACMC-209nwd; Opera_ID_711; [1,10]-Phenanthroline; Lopac-P-9375; Activ-8 in hexylene glycol; cid_1318; SCHEMBL8312; NCIStruc1_000192; NCIStruc2_000199; Lopac0_000985; KSC241K8T; ARONIS014409; DTXSID1025857; WLN: T B666 CN NNJ; 1,10 CPhenanthroline anhydrous; NCI4265; 1,10-Phenanthroline (anhydrous); 1,10-Phenanthroline, >=99%; 1,10-Phenanthroline,hydrochloride; HMS2234D03; HMS3263E11; HMS3371F11; ZINC164363; KS-000044UM; Tox21_201998; Tox21_303111; Tox21_500985; ANW-35243; BDBM50092158; CCG-38059; LS-284; NCGC00013043; SBB089685; STL069281; AKOS000281773; CS-W004544; DB02365; HY-W004544; LP00985; MCULE-2911225521; NSC-203545; RTR-022535; SDCCGSBI-0050958.P003; TRA0078227; NCGC00013043-02; NCGC00013043-03; NCGC00013043-04; NCGC00013043-05; NCGC00013043-06; NCGC00013043-07; NCGC00013043-08; NCGC00013043-09; NCGC00013043-10; NCGC00091201-01; NCGC00091201-02; NCGC00091201-03; NCGC00091201-04; NCGC00257123-01; NCGC00259547-01; NCGC00261670-01; AC-18353; AK-27000; AS-14043; BR-27000; K835; NCI60_003976; P116; SC-23392; AB1003025; DB-013750; TR-022535; EU-0100985; FT-0606035; FT-0660636; P0221; P0879; P1826; ST45051101; Solution forms containing 1,10-phenanthroline; C-1044; C00604; M-5271; P 9375; 011P678; A835532; AA-860/25004133; Q416005; SR-01000076093; CU-00000000156-1; J-610043; SR-01000076093-1; W-104740; F3377-1129; 1,10-Phenanthroline in combination with isoniazid and rifampicin; InChI=1/C12H8N2/c1-3-9-5-6-10-4-2-8-14-12(10)11(9)13-7-1/h1-8; CCRIS 4855
1,2-Dimethoxyethane 1,2-DIMETHOXYETHANE; 110-71-4; Monoglyme; Ethylene glycol dimethyl ether; Glyme; Dimethyl Cellosolve; Ethane, 1,2-dimethoxy-; Dimethoxyethane; 2,5-Dioxahexane; Egdme; Glycol dimethyl ether; Ethylene dimethyl ether; Hisolve MMM; Ansul ether 121; 1,2-Dimethoxyethan; Dimethylglycol; DME (glycol ether); Dimethyl Glycol; Monoethylene glycol dimethyl ether; mono-Glyme; Dimethylcellosolve; 1,2-Ethanediol dimethyl ether; CH3OCH2CH2OCH3; Ethylenglycoldimethylether; Ethylenglykoldimethylether; UNII-GXS24JF5IW; NSC 60542; HSDB 73; 1.2-dimethoxyethane; .alpha.,.beta.-Dimethoxyethane; 1,2-dimethoxy ethane; 1,2-dimethoxy-ethane; 1, 2-Dimethoxyethane; alpha,beta-Dimethoxyethane; EINECS 203-794-9; MFCD00008502; UN2252; GXS24JF5IW; BRN 1209237; ethyleneglycol dimethyl ether; AI3-61007; CHEBI:42263; XTHFKEDIFFGKHM-UHFFFAOYSA-N; DXE; 143585-58-4; dimetoxyethane; Selexol; 1,2dimethoxyethane; 1,2 dimethoxyethan; 1,2-dimethoxyetane; 1,2-dimetoxyethane; Genosorb 175; Genosorb 300; 1,2 dimethoxyethane; 1,2-dimethoxiethane; 1,2~dimethoxyethane; Varonic DM 55; Ethane,2-dimethoxy-; 1,2 dimethoxyetharie; 1,2 dimethoxylethane; 1,2-dimethoxylethane; 1,2-dimethyoxyethane; Glyme-23; Sanfine DM 200; Sanfine DM 400; 1,2-dimethyloxyethane; 1,2 -dimethoxyethane; 1,2,-dimethoxyethane; 1,2- dimethoxyethane; 1,2-di-methoxyethane; 1,2-dimethoxye-thane; PubChem18652; Sanfine DM 1000; Carpol CLE 1000; 1,2 -dimethoxy ethane; Nissan Unisafe MM 400; DSSTox_CID_5286; 1,2-bis(methyloxy)ethane; EC 203-794-9; Nissan Unisafe MM 1000; ethylene glycol dimethylether; U-Nox DM 200; CH3O(CH2CH2O)nCH3; Dimethoxy polyethylene glycol; DSSTox_RID_77727; DSSTox_GSID_25286; (2-methoxy)ethylmethyl ether; Polyoxyethylene dimethyl ether; U-Nox DM 1000; 4-01-00-02376 (Beilstein Handbook Reference); ethylene-glycol dimethyl ether; KSC175Q8B; ACMC-20996z; PEG-DME 2000; monoethylene glycol dimethylether; CHEMBL1232411; dimethylene glycol dimethyl ether; DTXSID0025286; CTK0H5880; Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-methoxy-; BCP30022; NSC60542; ZINC1690289; Tox21_200420; ANW-16185; LS-514; NSC-60542; STL282726; Glycols, polyethylene, dimethyl ether; AKOS009029143; alpha,omega-Methoxypoly(ethylene oxide); DB01749; MCULE-7572196731; RTR-002186; SB13076; UN 2252; 1,2-Dimethoxyethane, purification grade; KS-000002N5; 1,2-Dimethoxyethane, analytical standard; NCGC00248602-01; NCGC00257974-01; CAS-110-71-4; SC-16461; TR-002186; D0634; FT-0606419; FT-0688120; 5020-EP2269977A2; 5020-EP2269989A1; 5020-EP2269993A1; 5020-EP2270003A1; 5020-EP2270006A1; 5020-EP2270011A1; 5020-EP2272517A1; 5020-EP2272832A1; 5020-EP2275469A1; 5020-EP2277858A1; 5020-EP2277865A1; 5020-EP2280009A1; 5020-EP2281817A1; 5020-EP2281818A1; 5020-EP2281819A1; 5020-EP2287940A1; 5020-EP2289868A1; 5020-EP2289877A1; 5020-EP2289887A2; 5020-EP2289888A2; 5020-EP2289897A1; 5020-EP2289965A1; 5020-EP2292222A1; 5020-EP2292595A1; 5020-EP2292596A2; 5020-EP2292597A1; 5020-EP2292618A1; 5020-EP2295406A1; 5020-EP2295412A1; 5020-EP2295413A1; 5020-EP2295414A1; 5020-EP2295429A1; 5020-EP2298729A1; 5020-EP2298731A1; 5020-EP2298735A1; 5020-EP2298739A1; 5020-EP2298750A1; 5020-EP2298763A1; 5020-EP2298767A1; 5020-EP2298770A1; 5020-EP2298774A1; 5020-EP2298828A1; 5020-EP2299785A1; 5020-EP2301536A1; 5020-EP2301538A1; 5020-EP2301921A1; 5020-EP2301922A1; 5020-EP2301923A1; 5020-EP2301926A1; 5020-EP2301983A1; 5020-EP2305629A1; 5020-EP2305641A1; 5020-EP2305650A1; 5020-EP2305651A1; 5020-EP2305676A1; 5020-EP2305682A1; 5020-EP2305684A1; 5020-EP2306788A1; 5020-EP2306789A1; 5020-EP2308510A1; 5020-EP2308562A2; 5020-EP2308838A1; 5020-EP2308840A1; 5020-EP2308848A1; 5020-EP2308854A1; 5020-EP2308857A1; 5020-EP2308867A2; 5020-EP2308869A1; 5020-EP2308870A2; 5020-EP2308873A1; 5020-EP2308877A1; 5020-EP2308879A1; 5020-EP2308926A1; 5020-EP2309564A1; 5020-EP2309584A1; 5020-EP2311455A1; 5020-EP2311801A1; 5020-EP2311802A1; 5020-EP2311803A1; 5020-EP2311808A1; 5020-EP2311818A1; 5020-EP2311829A1; 5020-EP2311832A1; 5020-EP2311833A1; 5020-EP2311837A1; 5020-EP2314558A1; 5020-EP2314571A2; 5020-EP2314576A1; 5020-EP2314577A1; 5020-EP2314587A1; 5020-EP2315303A1; 5020-EP2316452A1; 5020-EP2316824A1; 5020-EP2316828A1; 5020-EP2371810A1; 5020-EP2371811A2; 5020-EP2371814A1; 5020-EP2371831A1; 5020-EP2372804A1; 5020-EP2378585A1; 5021-EP2269977A2; 5021-EP2269992A1; 5021-EP2269993A1; 5021-EP2270006A1; 5021-EP2270011A1; 5021-EP2272517A1; 5021-EP2272822A1; 5021-EP2272827A1; 5021-EP2272839A1; 5021-EP2272840A1; 5021-EP2275411A2; 5021-EP2275412A1; 5021-EP2277858A1; 5021-EP2277865A1; 5021-EP2277878A1; 5021-EP2281563A1; 5021-EP2281819A1; 5021-EP2284157A1; 5021-EP2284174A1; 5021-EP2286812A1; 5021-EP2287167A1; 5021-EP2292595A1; 5021-EP2292606A1; 5021-EP2292610A1; 5021-EP2295412A1; 5021-EP2295413A1; 5021-EP2295428A2; 5021-EP2298735A1; 5021-EP2298761A1; 5021-EP2298770A1; 5021-EP2298774A1; 5021-EP2301921A1; 5021-EP2301922A1; 5021-EP2301923A1; 5021-EP2301926A1; 5021-EP2301931A1; 5021-EP2305671A1; 5021-EP2305672A1; 5021-EP2305682A1; 5021-EP2305684A1; 5021-EP2305687A1; 5021-EP2308812A2; 5021-EP2308840A1; 5021-EP2308848A1; 5021-EP2308849A1; 5021-EP2308861A1; 5021-EP2308867A2; 5021-EP2308869A1; 5021-EP2308870A2; 5021-EP2308879A1; 5021-EP2308880A1; 5021-EP2311807A1; 5021-EP2311815A1; 5021-EP2311818A1; 5021-EP2311825A1; 5021-EP2311837A1; 5021-EP2311842A2; 5021-EP2314295A1; 5021-EP2314577A1; 5021-EP2316824A1; 5021-EP2316828A1; 5021-EP2316834A1; 5021-EP2316835A1; 5021-EP2371799A1; 5021-EP2371812A1; 5021-EP2374790A1; 5021-EP2374791A1; ASTM D4815/D5599 1,2-Dimethoxyethane IS; 12063-EP2269986A1; 12063-EP2269990A1; 12063-EP2269993A1; 12063-EP2270001A1; 12063-EP2272509A1; 12063-EP2272516A2; 12063-EP2272813A2; 12063-EP2272817A1; 12063-EP2272832A1; 12063-EP2275395A2; 12063-EP2275409A1; 12063-EP2275411A2; 12063-EP2277878A1; 12063-EP2279750A1; 12063-EP2284159A1; 12063-EP2284174A1; 12063-EP2287141A1; 12063-EP2287147A2; 12063-EP2289510A1; 12063-EP2289868A1; 12063-EP2292228A1; 12063-EP2292592A1; 12063-EP2292593A2; 12063-EP2292606A1; 12063-EP2295399A2; 12063-EP2295402A2; 12063-EP2295406A1; 12063-EP2295423A1; 12063-EP2298731A1; 12063-EP2298744A2; 12063-EP2298756A1; 12063-EP2298763A1; 12063-EP2298767A1; 12063-EP2298768A1; 12063-EP2298770A1; 12063-EP2298772A1; 12063-EP2298777A2; 12063-EP2299785A1; 12063-EP2301933A1; 12063-EP2301934A1; 12063-EP2301937A1; 12063-EP2305633A1; 12063-EP2305643A1; 12063-EP2305667A2; 12063-EP2305682A1; 12063-EP2306788A1; 12063-EP2306789A1; 12063-EP2308828A2; 12063-EP2308839A1; 12063-EP2308840A1; 12063-EP2308849A1; 12063-EP2308850A1; 12063-EP2308857A1; 12063-EP2308861A1; 12063-EP2308864A1; 12063-EP2308867A2; 12063-EP2308870A2; 12063-EP2308879A1; 12063-EP2308880A1; 12063-EP2311815A1; 12063-EP2311825A1; 12063-EP2311827A1; 12063-EP2311831A1; 12063-EP2311842A2; 12063-EP2311850A1; 12063-EP2314576A1; 12063-EP2314587A1; 12063-EP2315303A1; 12063-EP2316828A1; 12063-EP2316832A1; 12063-EP2316833A1; 12063-EP2371810A1; 32209-EP2284157A1; 32209-EP2289897A1; 32209-EP2295415A1; 32209-EP2301924A1; 32209-EP2301933A1; 32209-EP2305682A1; 32209-EP2305825A1; 32209-EP2308862A1; 32209-EP2308879A1; 32209-EP2311827A1; 38769-EP2270006A1; 38769-EP2280001A1; 38769-EP2281817A1; 38769-EP2298735A1; 38769-EP2311837A1; 57146-EP2272846A1; 57146-EP2275411A2; 57146-EP2277868A1; 57146-EP2277869A1; 57146-EP2277870A1; 57146-EP2287147A2; 57146-EP2298769A1; 57146-EP2308878A2; 1,2-Dimethoxyethane, SAJ first grade, >=99.0%; 124755-EP2269977A2; 124755-EP2295426A1; 124755-EP2295427A1; A802238; Q416271; 1,2-Dimethoxyethane [UN2252] [Flammable liquid]; 1,2-Dimethoxyethane [UN2252] [Flammable liquid]; alpha-Methyl-omega-methoxypoly(oxy-1,2-ethanediyl); J-503827; Ethylene glycol dimethyl ether (1,2-Dimethoxyethane); 1,2-Dimethoxyethane, anhydrous, 99.5%, inhibitor-free; 1,2-Dimethoxyethane, for HPLC, 99.9%, inhibitor-free; 1,2-ETHANEDIOL,DIMETHYL ETHER (DIMETHYLGLYCOL); F1908-0122; Poly(oxy-1,2-ethanediyl), alpha-methyl-omega-methoxy-; 1,2-Dimethoxyethane, ReagentPlus(R), >=99%, inhibitor-free; InChI=1/C4H10O2/c1-5-3-4-6-2/h3-4H2,1-2H; 1,2-Dimethoxyethane, anhydrous, inhibitor-free, ZerO2(TM), 99.5%; Ethylene dimethyl ether; 1,2-dimethoxy-ethan; Ethylene glycol dimethyl ether; 4-01-00-02376 (Beilstein Handbook Reference)
1,3,5-Trichlorobenzene 1,3,5-TRICHLOROBENZENE; 108-70-3; s-Trichlorobenzene; sym-Trichlorobenzene; Benzene, 1,3,5-trichloro-; 1,3,5-TRICHLORO-BENZENE; UNII-2HS4M0BX3C; CCRIS 5946; HSDB 132; NSC 4389; EINECS 203-608-6; 2HS4M0BX3C; AI3-22031; CHEBI:49916; XKEFYDZQGKAQCN-UHFFFAOYSA-N; 1,5-Trichlorobenzene; TCB; Trichlorobenzene; PubChem23744; 1,3,5-Trichlorbenzol; 2,4,6-trichlorobenzene; Benzene,3,5-trichloro-; DSSTox_CID_6195; Symmetrical trichlorobenzene; benzene,1,3,5-trichloro-; ACMC-1BV03; DSSTox_RID_78053; DSSTox_GSID_26195; KSC176K3T; CHEMBL44228; SCHEMBL429512; 1,3,5-tris(chloranyl)benzene; DTXSID8026195; CTK0H6539; KS-00000VCL; 1,3,5-Trichlorobenzene, 99%; NSC4389; ZINC391973; EBD10916; NSC-4389; Tox21_200279; ANW-15972; LS-468; MFCD00000585; SBB060226; AKOS015888162; DB03836; MCULE-9710772952; NE10039; RTR-001985; NCGC00091181-01; NCGC00091181-02; NCGC00257833-01; CAS-108-70-3; I834; PS-10255; SC-16080; TCZ; ST2414781; TR-001985; 1,3,5-Trichlorobenzene, analytical standard; FT-0606508; ST50406121; 08T703; Benzene, 1,3,5-trichloro-, radical ion(1-); A801916; 1,3,5-Trichlorobenzene 100 microg/mL in Methanol; J-503845; Q2031856; 1,3,5-Trichlorobenzene 10 microg/mL in Acetonitrile; 1,3,5-Trichlorobenzene 10 microg/mL in Cyclohexane; Z1695906707; 1,3,5-Trichlorobenzene, PESTANAL(R), analytical standard; UNII-5K7N3LID79 component XKEFYDZQGKAQCN-UHFFFAOYSA-N; InChI=1/C6H3Cl3/c7-4-1-5(8)3-6(9)2-4/h1-3; 1,3,5-Trichlorobenzene, certified reference material, TraceCERT(R); AI3-22031
1,3-Diphenylurea Carbanilide; 1,3-Diphenylurea; N,N'-Diphenylurea; 102-07-8; CARBANILIDE; Diphenylurea; Diphenylcarbamide; Urea, N,N'-diphenyl-; s-Diphenylurea; sym-Diphenylurea; Acardite I; N-Phenyl-N'-phenylurea; Acardite; 1,3-Diphenylcarbamide; Karbanilid; N,N'-Difenylmocovina; USAF EK-534; Urea, 1,3-diphenyl-; Karbanilid [Czech]; 1,3-diphenyl-urea; AD 30; UNII-94YD8RMX5B; NSC 227401; N,N'-Difenylmocovina [Czech]; CCRIS 4634; HSDB 2757; Urea-based compound, 7; EINECS 203-003-7; BRN 0782650; 94YD8RMX5B; AI3-52320; CHEBI:41320; GWEHVDNNLFDJLR-UHFFFAOYSA-N; Urea,3-diphenyl-; Urea,N'-diphenyl-; MFCD00003017; WLN: RMVMR; N,N'-Diphenylurea, 97%; F0316-0002; N-phenyl(phenylamino)carboxamide; N'N'-Diphenyl urea; SR-01000398115; bis-phenyl-urea; Zeonet U; 2zjf; n,n'-diphenyl-urea; N, N'-diphenylurea; N,N'-diphenyl urea; 1, 3-Diphenylurea; Kinome_598; Kinome_627; N,N'-bis-Phenylurea; Spectrum_000422; SpecPlus_000406; Spectrum2_001838; Spectrum3_001328; Spectrum4_001561; Spectrum5_000182; DSSTox_CID_5183; 1 pound not3-diphynylurea; 1,3-Diphenylurea, 98%; DSSTox_RID_77698; DSSTox_GSID_25183; Oprea1_527136; BSPBio_003055; CBDivE_002165; KBioGR_002082; KBioSS_000902; SPECTRUM211126; 4-12-00-00741 (Beilstein Handbook Reference); KSC175E2F; MLS002207104; DivK1c_006502; SCHEMBL133103; SPBio_001915; CHEMBL354676; DTXSID2025183; SCHEMBL21313806; BDBM25725; CTK0H5222; KBio1_001446; KBio2_000902; KBio2_003470; KBio2_006038; KBio3_002275; KS-00000WTV; NSC8485; 3e85; ACMC-209800; NSC-8485; RKL10128; Tox21_200068; ANW-14638; CCG-38465; GEO-04213; ICCB1_000093; LS-354; NSC227401; SBB058217; STK328350; ZINC12416741; AKOS000312994; DB07496; FS-4202; MCULE-4684667909; NSC-227401; RTR-000546; SDCCGMLS-0066513.P001; TRA0086633; VZ36373; NCGC00091344-01; NCGC00091344-02; NCGC00091344-03; NCGC00091344-04; NCGC00091344-05; NCGC00257622-01; AC-12855; AK106179; CAS-102-07-8; SMR000112141; Carbanalide 100 microg/mL in Acetonitrile; AB1002487; TR-000546; EU-0067898; FT-0606720; ST45141119; L-5305; 1,3-Diphenylurea, Vetec(TM) reagent grade, 98%; AQ-917/40171059; SR-01000398115-1; SR-01000398115-2; W-108886; BRD-K13027645-001-02-0; Q27096716; N,N inverted exclamation marka-Diphenylurea; Carbanilide; InChI=1/C13H12N2O/c16-13(14-11-7-3-1-4-8-11)15-12-9-5-2-6-10-12/h1-10H,(H2,14,15,16; 4-12-00-00741 (Beilstein Handbook Reference)
1,3-Propanediol 1,3-PROPANEDIOL; Propane-1,3-diol; 504-63-2; Trimethylene glycol; 1,3-Dihydroxypropane; 1,3-Propylene glycol; 2-Deoxyglycerol; 1,3-PROPANDIOL; 1,3-Propylenediol; 2-(Hydroxymethyl)ethanol; beta-Propylene glycol; omega-Propanediol; .beta.-Propylene glycol; NSC 65426; .omega.-Propanediol; UNII-5965N8W85T; AI3-01851; HOCH2CH2CH2OH; EINECS 207-997-3; 1,3-Propanediol, 98%; BRN 0969155; HO(CH2)3OH; CHEBI:16109; YPFDHNVEDLHUCE-UHFFFAOYSA-N; 5965N8W85T; 284474-77-7; 3-hydroxypropanol; 1,3 propanediol; 1.3-propanediol; propane-1,3diol; propane1,3-diol; propane1.3-diol; 1,3 propandiol; propan-1,3-diol; 1,3 -propanediol; 1,3- propanediol; 1,3-propane diol; 1,3-propane-diol; propane 1,3-diol; propane 1.3-diol; propane diol-1,3; propane-1-3-diol; propane-1.3-diol; MFCD00002949; 1,3-propyleneglycol; propane-1, 3-diol; propanediol-(1,3); PubChem22258; ACMC-209kmt; bmse000303; EC 207-997-3; DSSTox_CID_21246; DSSTox_RID_79660; DSSTox_GSID_41246; KSC270C6L; (HOCH2)2CH2; 1,3-Propanediol, homopolymer; CH2(CH2OH)2; CHEMBL379652; DTXSID8041246; CTK1H0165; HSDB 8263; DTXSID30897465; 1,3-Propanediol, >=99.6%; NSC65426; ZINC1529437; Tox21_300750; ANW-31011; NSC-65426; STL282728; AKOS000269061; CS-W018490; DB02774; MCULE-5166824786; RTR-018033; TRA0097189; NCGC00248157-01; NCGC00254655-01; BP-30193; CAS-504-63-2; SC-25736; DB-071203; LS-120102; TR-018033; 1,3-Propanediol 100 microg/mL in Methanol; FT-0606743; P0486; 1,3-Propanediol, puriss., >=99.0% (GC); 1750-EP2269998A2; 1750-EP2270005A1; 1750-EP2272517A1; 1750-EP2272832A1; 1750-EP2272834A1; 1750-EP2272846A1; 1750-EP2272848A1; 1750-EP2275412A1; 1750-EP2277507A1; 1750-EP2281563A1; 1750-EP2286795A1; 1750-EP2287153A1; 1750-EP2289483A1; 1750-EP2292625A1; 1750-EP2295414A1; 1750-EP2295439A1; 1750-EP2298764A1; 1750-EP2298765A1; 1750-EP2301929A1; 1750-EP2301933A1; 1750-EP2301935A1; 1750-EP2305254A1; 1750-EP2305648A1; 1750-EP2305653A1; 1750-EP2305674A1; 1750-EP2305688A1; 1750-EP2305808A1; 1750-EP2308510A1; 1750-EP2308562A2; 1750-EP2308866A1; 1750-EP2308872A1; 1750-EP2308873A1; 1750-EP2311801A1; 1750-EP2311822A1; 1750-EP2311827A1; 1750-EP2311840A1; 1750-EP2316459A1; 1750-EP2316824A1; 1750-EP2316826A1; 1750-EP2316829A1; 1750-EP2371805A1; 1750-EP2371811A2; 1750-EP2371814A1; C02457; 32978-EP2284159A1; 32978-EP2301933A1; 32978-EP2311827A1; 68915-EP2270101A1; 68915-EP2275417A2; 68915-EP2284162A2; 68915-EP2284163A2; 68915-EP2292597A1; 68915-EP2292606A1; 68915-EP2295399A2; 68915-EP2301919A1; 68915-EP2308861A1; 68915-EP2377842A1; 68915-EP2380568A1; 1,3-Propanediol, Vetec(TM) reagent grade, 98%; A828134; Q161514; J-503943; InChI=1/C3H8O2/c4-2-1-3-5/h4-5H,1-3H; F1908-0064; 7AB97F71-EF6B-4C05-8084-541427B9306C; 1,3-Propanediol, United States Pharmacopeia (USP) Reference Standard; 345260-48-2; 4-01-00-02493 (Beilstein Handbook Reference)
1,4-Butanediol 1,4-BUTANEDIOL; Butane-1,4-diol; 110-63-4; 1,4-Butylene glycol; Tetramethylene glycol; 1,4-Dihydroxybutane; 1,4-Tetramethylene glycol; Tetramethylene 1,4-diol; Sucol B; 1,4-BD; DIOL 14B; Agrisynth B1D; UNII-7XOO2LE6G3; HO(CH2)4OH; NSC 406696; CCRIS 5984; HSDB 1112; EINECS 203-786-5; MFCD00002968; HOCH2CH2CH2CH2OH; BRN 1633445; 7XOO2LE6G3; AI3-07553; CHEBI:41189; WERYXYBDKMZEQL-UHFFFAOYSA-N; DSSTox_CID_4666; DSSTox_RID_77492; DSSTox_GSID_24666; BDO; BU1; CAS-110-63-4; 1,4-Butanediol, homopolymer; 4-hydroxybutanol; 1,4butanediol; 1.4-butanediol; Dabco BDO; 1,4-butandiol; 1,4-butane diol; 1,4-butane-diol; butane 1,4-diol; butane diol-1,4; butane-1-4-diol; 1,4- butandiol; Butan-1.4-diol; 1.4 - butanediol; 1,4 butylene glycol; ACMC-1BRE8; 1,4-Butanediol, 99%; EC 203-786-5; WLN: Q4Q; 4-01-00-02515 (Beilstein Handbook Reference); KSC175Q8N; MLS001061198; 1,4-Butanediol 4 M solution; CHEMBL171623; DTXSID2024666; CTK0H5886; KS-00000WMZ; HMS3039N12; ZINC1599375; Tox21_202245; Tox21_303040; ANW-16175; LS-512; NSC406696; STL283940; AKOS000118735; 1,4-Butanediol, for synthesis, 98%; CS-W016669; DB01955; MCULE-2010022287; NSC-406696; RTR-032026; TRA0075312; 1,4-Butanediol, ReagentPlus(R), 99%; NCGC00090733-01; NCGC00090733-02; NCGC00257119-01; NCGC00259794-01; 28324-25-6; BP-21418; SC-79277; SMR000677930; 1,4-Butanediol 100 microg/mL in Methanol; 1,4-Butanediol, ReagentPlus(R), >=99%; TR-032026; B0680; FT-0606811; ST24046254; 3379-EP2272849A1; 3379-EP2292597A1; 3379-EP2301919A1; 3379-EP2305668A1; 1,4-Butanediol, Vetec(TM) reagent grade, 98%; 48881-EP2270101A1; 48881-EP2275417A2; 48881-EP2284162A2; 48881-EP2284163A2; 48881-EP2284165A1; 48881-EP2295399A2; 48881-EP2295438A1; 48881-EP2308865A1; 48881-EP2311841A1; 48881-EP2371797A1; 48881-EP2371798A1; 48881-EP2371805A1; 48881-EP2380568A1; 48881-EP2380873A1; Q161521; J-503971; J-512798; F0001-0222; Z1259087047; InChI=1/C4H10O2/c5-3-1-2-4-6/h5-6H,1-4H; UNII-TMS4MGA0H4 component WERYXYBDKMZEQL-UHFFFAOYSA-N; 1,4-Butanediol solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material; 4-01-00-02515 (Beilstein Handbook Reference)
1-(3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride 1-(3-chloro-2-propen-1-yl)-3,5,7-Triaza-1-azoniatricyclo[3.3.1.13,7]decane chloride (1:1); N-(3-Chloroallyl)hexaminium chloride; Caswell No. 181
1-Aminocyclopropane-1-carboxylic acid 1-Aminocyclopropanecarboxylic acid; 1-Aminocyclopropane-1-carboxylic acid; 4-14-00-00973 (Beilstein Handbook Reference)
1-Benzylimidazole 1-(Phenylmethyl)-1H-imidazole; 1-Benzylimidazole; AI3-52572
1-Decanethiol 1-DECANETHIOL; 143-10-2; decane-1-thiol; Decyl mercaptan; 1-Mercaptodecane; decanethiol; Decylmercaptan; n-Decyl mercaptan; Decanethiol-(1); VTXVGVNLYGSIAR-UHFFFAOYSA-N; decanthiol; n-decanethiol; n-decanthiol; 1-decylthiol; NSC 850; n-decane-1-thiol; D1T; EINECS 205-584-2; tert-Decyl mercaptan; 1-DECANTHIOL; 1-Decanethiol, 96%; 1-Decanethiol, 99%; ACMC-1BRTR; AI3-06520; SCHEMBL93416; NSC850; DTXSID7059727; CTK0H8650; NSC-850; KS-000014PN; ZX-AT008207; EINECS 250-081-3; 5781AF; ANW-20742; MFCD00004884; ZINC16052462; AKOS015897633; DB07611; MCULE-5945458624; CC-04428; 1-Decanethiol, technical, >=95% (GC); DB-021361; RT-004663; D0016; FT-0607690; C-34044; J-007742; Q27096831; AI3-06520
1-Dodecanesulphonic acid 1-Dodecanesulfonic acid, Ion(1-); 1-Dodecanesulfonic acid, ion(1-); Dodecylsulfonate
1-Naphthoxyacetic acid 2-(1-Naphthalenyloxy)acetic acid; 1-Naphthoxyacetic acid; EINECS 221-023-4
1H-Benzimidazole-2-carboxylic acid
2,3,4,6-Tetrahydroxy-5H-benzo[7]annulen-5-one Pururogallin 1,2,3-trihydroxybenztropolone; Purpurogallin; 4-08-00-03456 (Beilstein Handbook Reference)
2,3-Dihydroxybenzoic acid 4-10-00-01414 (Beilstein Handbook Reference)
2,4,6-Trinitrotoluene 2-Methyl-1,3,5-trinitrobenzene; 2,4,6-TRINITROTOLUENE; Trinitrotoluene; Trotyl; s-Trinitrotoluol; s-Trinitrotoluene; Tolite; Tritol; 2-Methyl-1,3,5-trinitrobenzene; 118-96-7; sym-Trinitrotoluol; trinitrotoluol; Trojnitrotoluen; Gradetol; Tolit; Tnt-tolite; Trotyl oil; alpha-TNT; 2,4,6-Trinitrotoluol; TNT; Tritol (explosive); Benzene, 2-methyl-1,3,5-trinitro-; Toluene, 2,4,6-trinitro-; sym-Trinitrotoluene; NCI-C56155; TNT-tolite [French]; Trinitrotoluen; 2,4,6-Trinitrotolueen; Trojnitrotoluen [Polish]; 1-Methyl-2,4,6-trinitrobenzene; UNII-H43RF5TRM5; NSC 36949; .alpha.-TNT; CCRIS 1299; HSDB 1146; 2,4,6-Trinitrotolueen [Dutch]; 2,4,6-Trinitrotoluol [German]; EINECS 204-289-6; 2,4,6-TNT; UN0209; UN1356; H43RF5TRM5; 2,4,6-trinitrotoluene (tnt); trilit; DTXSID7024372; CHEBI:46053; SPSSULHKWOKEEL-UHFFFAOYSA-N; 2,4,6-trinitritoluene; Trinitrotoluene or TNT, dry or wetted with < 30% water, by mass; TNL; alpha-trinitrotoluol; Trinitrotoluene, dry; Trinitrotoluene, wet; 2,6-Trinitrotoluol; 2,6-Trinitrotolueen; 2,6-Trinitrotoluene; 2,4,6-trinitro-toluene; EC 204-289-6; SCHEMBL20676; UN 0209 (Salt/Mix); UN 1356 (Salt/Mix); WLN: WNR B1 CNW ENW; 2-Methyl-1,5-trinitrobenzene; Toluene,4,6-trinitro- (wet); CHEMBL1236345; SCHEMBL12305492; CTK8E4069; 1-methyl-2,4,6-trinitrotoluene; NSC36949; NSC-36949; ZINC14880028; AKOS001092689; DB01676; MCULE-8164226079; LS-154211; TR-032836; FT-0609917; C16391; C-47366; Q170167; Trinitrotoluene, wetted with not <30% water, by mass; Z57056414; 2,4,6-Trinitrotoluene (TNT) 10 microg/mL in Cyclohexane; 2,4,6-Trinitrotoluene (TNT) 100 microg/mL in Cyclohexane; Trinitrotoluene or TNT, dry or wetted with <30% water, by mass; Trinitrotoluene or TNT, dry or wetted with <30% water, by mass [UN0209] [Explosive 1.1D]; Trinitrotoluene, wetted with not <30% water, by mass [UN1356] [Flammable solid]; Trinitrotoluene, wetted with not <30% water, by mass [UN1356] [Flammable solid]; 2,4,6-Trinitrotoluene solution, 10 mg/mL in acetonitrile, ampule of 5 mL, certified reference material; 2,4,6-Trinitrotoluene solution, 1000 mug/mL in acetonitrile, ampule of 1.2 mL, certified reference material; Trinitrotoluene or TNT, dry or wetted with <30% water, by mass [UN0209] [Explosive 1.1D]; Trinitrotoluene; Benzene, 2-methyl-1,3,5-trinitro-
2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 154447-36-6; LY294002; LY 294002; LY-294002; 2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; 2-morpholino-8-phenyl-4H-chromen-4-one; 2-morpholin-4-yl-8-phenyl-4H-chromen-4-one; UNII-31M2U1DVID; 2-(morpholin-4-yl)-8-phenyl-4H-chromen-4-one; 31M2U1DVID; 2-MORPHOLIN-4-YL-7-PHENYL-4H-CHROMEN-4-ONE; CHEMBL98350; 4H-1-Benzopyran-4-one, 2-(4-morpholinyl)-8-phenyl-; CHEBI:65329; 15447-36-6; AK162301; LY2; 4H-1-Benzopyran-4-one,2-(4-morpholinyl)-8-phenyl-; 4H-1-Benzopyran-4-one, 2-(4-morpholinyl)-8-phenyl; LY-294,002; 2-Morpholin-4-yl-8-phenyl-chromen-4-one; BMK1-D5; Lys 294002; 4azt; InSolution™ LY 294002; 2-morpholino-8-phenyl-chromen-4-one; NSC 697286; SF 1101; Kinome_3543; PubChem16766; Tocris-1130; 1yi3; BiomolKI_000029; 2-(morpholin-4-yl)-8-phenylchromen-4-one; Lopac-L-9908; 8-Phenyl-2-(morpholin-4-yl)-chromen-4-one; BiomolKI2_000037; cc-58; CBiol_002046; Lopac0_000710; SCHEMBL94377; BSPBio_001223; KBioGR_000563; KBioSS_000563; MLS006010131; 2-Morpholino-8-phenylchromone; 2-(4-morpholino)-8-phenyl-4H-1-benzopyran-4-one; GTPL6004; ZINC6014; DTXSID6042650; BCBcMAP01_000117; BDBM12915; CTK0H1979; KBio2_000563; KBio2_003131; KBio2_005699; KBio3_001005; KBio3_001006; BIL2940; EX-A073; SYN1108; CZQHHVNHHHRRDU-UHFFFAOYSA-N; ZX-AFC000490; BCPP000177; Bio1_000332; Bio1_000821; Bio1_001310; Bio2_000442; Bio2_000922; HMS1362M05; HMS1792M05; HMS1990M05; HMS3229G17; HMS3403M05; HMS3649E04; HMS3654M21; BCP00195; KS-00000XP3; HSCI1_000206; NSC697286; s1105; AKOS017344742; API0015880; BCP9000880; CCG-100633; CS-0150; DB02656; NSC-697286; QC-7260; SB10965; SDCCGSBI-0050688.P003; SF-1101; IDI1_002197; NCGC00015622-01; NCGC00015622-02; NCGC00015622-03; NCGC00015622-04; NCGC00015622-05; NCGC00015622-06; NCGC00015622-07; NCGC00025020-01; NCGC00025020-02; NCGC00025020-03; NCGC00025020-04; NCGC00179253-01; 4CA-0787; AC-30295; AS-16252; HY-10108; LS-39828; NCI60_034712; SC-85850; SMR002530642; AB0033714; LY-924002; RT-013609; FT-0660382; M2410; ST24040926; SW217688-2; X7411; EC-000.2341; 2-Morpholino-8-phenyl-4-oxo-4H-1-benzopyran; C15195; K00235; S-7706; J-510126; Q4042503; SR-01000076245-7; BRD-K27305650-001-05-9; LY-294,002 hydrochloride, solid, >=98% (HPLC); 4H-1-Benzopyran-4-one, 2-(4-morpholinyl)-8-phenyl- (9CI); H-1-Benzopyran-4-one, 2-(4-morpholinyl)-8-phenyl- (9CI); LY 294002; 2-(4-Morpholino)-8-phenyl-4H-1-benzopyran-4-one; LY 294002, LY-294002, 154447-36-6; LY-294002
2-Amino-2-deoxy-beta-D-galactopyranose beta-D-galactosamine; beta-galactosylamine; 2-DEOXY-2-AMINOGALACTOSE; UNII-K8YZM765ZS; 2-amino-2-deoxy-beta-D-galactopyranose; K8YZM765ZS; 1GN; beta-galactosamine; Galactosamine, beta-D-; SCHEMBL154587; CHEBI:39610; ZINC3861073; DB02678; beta-D-Galactopyranose, 2-amino-2-deoxy-; Q27093625; beta-D-Galactosamine; UNII-K8YZM765ZS
2-Amino-4-methylphenol 2-Amino-4-methylphenol; 2-Amino-p-cresol; 95-84-1; 2-Hydroxy-5-methylaniline; 3-Amino-4-hydroxytoluene; Phenol, 2-amino-4-methyl-; 6-Hydroxy-m-toluidine; 4-Methyl-2-aminophenol; 2-Amino-4-cresol; 5-Methyl-2-hydroxyaniline; p-Cresol, 2-amino-; 2-amino-4-methyl-phenol; 2-Amino-4-methyl phenol; CCRIS 4581; EINECS 202-457-3; NSC 60737; 2-Amino-p-cresol, 97%; BRN 0606494; UNII-9ZV2574SER; 9ZV2574SER; ZMXYNJXDULEQCK-UHFFFAOYSA-N; m-Amino-p-cresol; DSSTox_CID_4488; ACMC-209s5g; 2A4MP; DSSTox_RID_77424; DSSTox_GSID_24488; 4-13-00-01712 (Beilstein Handbook Reference); KSC490K7N; MLS002454361; SCHEMBL104502; CHEMBL224282; p-Cresol, 2-amino- (8CI); 2-Amino-4-methylphenol, 97%; DTXSID4024488; CTK3J0576; NSC7630; HMS3039M15; KUC106693N; ZINC388269; KS-00000JS9; NSC-7630; NSC60737; Tox21_200692; ANW-40754; BBL001485; MFCD00007699; NSC-60737; SBB051703; STL115535; AKOS000345514; CS-W004057; DB04533; LS-1993; MCULE-2502307131; NE10507; PS-5548; RTR-030074; TRA0084322; CAS-95-84-1; NCGC00091594-01; NCGC00091594-02; NCGC00091594-03; NCGC00258246-01; 2AC; AC-10115; AK114319; KSC-11-207-3; SC-76578; SMR001371986; AB1002789; TR-030074; A0330; FT-0611127; ST24021967; ST45255292; T7522; X4670; W-100153; 2-Amino-4-methylphenol, technical, >=98.0% (NT); Q27095299; F0001-2282; Z1259161979; 2-Amino-p-cresol; 2-Hydroxy-5-methylaniline; 3-Amino-4-hydroxytoluene; InChI=1/C7H9NO/c1-5-2-3-7(9)6(8)4-5/h2-4,9H,8H2,1H; 4-13-00-01712 (Beilstein Handbook Reference)
2-Aminoisobutyric acid 2-Methylalanine; 2-Aminoisobutyric acid; 62-57-7; 2-Methylalanine; 2-Amino-2-methylpropanoic acid; H-Aib-OH; ALPHA-AMINOISOBUTYRIC ACID; Alanine, 2-methyl-; 2-Amino-2-methylpropionic acid; alpha-Methylalanine; alpha-Aminoisobutanoic acid; alpha,alpha-Dimethylglycine; 2-Amino-2-methylpropanoate; a-Aminoisobutyric acid; 2-amino isobutyric acid; a-Aminoisobutyrate; NSC 16590; AIB; Propionic acid, 2-amino-2-methyl-; 2-amino-isobutyric acid; 2-amino-2-methyl-propanoic acid; UNII-1E7ZW41IQU; 2-Aminoisobutyrate; MFCD00008049; .alpha.-Aminoisobutanoic acid; 2,2-dimethylglycine; .alpha.-Methylalanine; EINECS 200-544-0; CB 1637; BRN 0506496; .alpha.-Aminoisobutyric acid; 1E7ZW41IQU; AI3-15082; .alpha.,.alpha.-Dimethylglycine; CHEBI:27971; FUOOLUPWFVMBKG-UHFFFAOYSA-N; 2-Aminoisobutyric acid, 98+%; 857402-27-8; a-Methylalanine; 2-methyl alanine; a-Aminoisobutanoate; Aminoisobutyric acid; 2-methyl-L-alanine; 2-AminoisobutyricAcid; alpha-Aminoisobutyrate; alpha-Aminoisobutanoate; a-Aminoisobutanoic acid; PubChem16474; ACMC-1AYLN; .alpha.-Aminoisobutyrate; alpha -aminoisobutyric acid; SCHEMBL23312; 4-04-00-02616 (Beilstein Handbook Reference); KSC355I4D; WLN: ZX1&1&VQ; 2-Aminoisobutyric acid, 98%; CHEMBL1230906; DTXSID0058772; 2-amino-2-methyl-propionic acid; CTK2F5441; KS-00000ADT; ZINC901801; ACT04808; ALBB-006012; CS-B0930; HY-Y0124; NSC16590; Propanoic acid, 2-amino-2-methyl-; ANW-34269; BBL027672; LMFA01100053; NSC-16590; s6270; SBB028178; STK034507; AKOS000195995; AB00918; AC-2694; ACN-001466; DB02952; LS41573; MCULE-4254251799; RTR-032140; TRA0018563; 765258-64-8; AK-47379; AS-15790; BP-12097; BR-47379; LS-16154; Q794; SC-25938; SY002590; TR-032140; A0323; AM20100517; BB 0253767; FT-0611252; FT-0635088; ST24032388; ST45022003; EN300-53414; A22742; C-4595; C03665; 34103-EP2295055A2; 34103-EP2301923A1; 34103-EP2311453A1; J-300332; Q4596860; alpha-Aminoisobutyric acid, puriss., >=99.0% (NT); 5085F756-CF99-4860-BBBD-469F4BDEF53C; F8889-8339; Z1250208638; InChI=1/C4H9NO2/c1-4(2,5)3(6)7/h5H2,1-2H3,(H,6,7; N-Me-alanine; N-Me-ala-oh; DL-2-Amino-iso-butyric acid; H-2-Aminoisobutyric acid; 2-Aminoisobutyric acid; 4-04-00-02616 (Beilstein Handbook Reference)
2-Aminophenol 2-Aminophenol; 95-55-6; O-AMINOPHENOL; o-Hydroxyaniline; 2-Hydroxyaniline; Phenol, 2-amino-; 2-Amino-1-hydroxybenzene; Fouramine OP; ortho-aminophenol; Benzofur GG; Pelagol Grey GG; Pelagol 3GA; Nako Yellow 3GA; Phenol, o-amino-; BASF ursol 3GA; 2-Hydroxyanaline; Nako Yellow ga; Zoba 3GA; Aminophenol; o-Hydroxyphenylamine; Paradone Olive Green B; Questiomycin B; 2-Aminobenzenol; 1-Amino-2-hydroxybenzene; 1-Hydroxy-2-aminobenzene; C.I. Oxidation Base 17; CI Oxidation Base 17; C.I. 76520; ORTHO AMINO PHENOL; 2-amino phenol; 2-amino-phenol; NSC 1534; UN2512; UNII-23RH73DZ65; CCRIS 4144; CI 76520; CHEBI:18112; AI3-09065; HSDB 4246; 2-Aminophenol, 99%; 2-AMINO-PHENOLE; 2-HYDROXYLANILINE; EINECS 202-431-1; CDAWCLOXVUBKRW-UHFFFAOYSA-N; 23RH73DZ65; c0316; MFCD00007690; STK286021; o-Aminophenol [UN2512] [Poison]; NCGC00091188-01; 2AF; amino-phenol; O-Amino phenol; 2-hydroxybenzenamine; ZINC00157526; 2-aminohydroxybenzene; 2-Aminophenyl alcohol; O-AMINOPHENL; 2-amino-hydroxybenzene; ACMC-209rze; DSSTox_CID_4498; WLN: ZR BQ; bmse000310; Epitope ID:128160; UN 2512 (Related); EC 202-431-1; DSSTox_RID_77428; DSSTox_GSID_24498; SCHEMBL24436; 27598-85-2; KSC206E4P; MLS002454422; BIDD:GT0801; CHEMBL28319; Benzene, 1-hydroxy-2-amine-; 36683_RIEDEL; DTXSID8024498; CTK1A6247; EXPT00102; KS-00000XEM; TIMTEC-BB SBB040832; EBD1686; NSC1534; 3-bromo-1-methyl-quinolin-2-one; HMS3039N03; LABOTEST-BB LTBB000484; ZINC157526; 2-Aminophenol, puriss., 99.5%; ACT07280; CS-D1201; NSC-1534; STR00335; AKOS BBS-00004290; Tox21_200932; ANW-40536; o-Aminophenol [UN2512] [Poison]; SBB040832; AKOS000119785; AS00211; DB01726; DF10085; LS-1981; MCULE-7578442073; RTR-032625; TRA0027746; CAS-95-55-6; NCGC00091188-02; NCGC00091188-03; NCGC00258486-01; BP-13471; H441; SC-22377; SMR001372016; AB1002390; DB-024292; o-Hydroxyaniline; 2-Amino-1-hydroxybenzene; ST2409589; TR-032625; 2-Aminophenol, purum, >=98.0% (HPLC); A0335; FT-0611259; ST50214414; AZ0001-0117; C01987; M-5557; 51204-EP2270006A1; 51204-EP2278637A1; 51204-EP2311824A1; 51204-EP2371803A1; 51204-EP2377843A1; 82735-EP2292608A1; 82735-EP2295432A1; 82735-EP2298758A1; 82735-EP2298759A1; 82735-EP2305664A1; 2-Aminophenol, PESTANAL(R), analytical standard; Q1089204; W-100162; 8CFFFA6B-6ACF-4377-B782-47586CF00CCB; Z57127952; F2190-0437; UNII-LST7140D72 component CDAWCLOXVUBKRW-UHFFFAOYSA-N; InChI=1/C6H7NO/c7-5-3-1-2-4-6(5)8/h1-4,8H,7H; Mesalazine impurity C, European Pharmacopoeia (EP) Reference Standard; 2-Aminophenol (Mesalazine Impurity C - PhEur), Pharmaceutical Secondary Standard; Certified Reference Material; o-Aminophenol; C.I. 76520
2-Chloro-6-methylaniline 2-Chloro-6-methylbenzenamine; 2-Chloro-6-methylaniline; 87-63-8; 6-CHLORO-2-METHYLANILINE; 6-Chloro-o-toluidine; 2-Amino-3-chlorotoluene; Benzenamine, 2-chloro-6-methyl-; 3-Chloro-2-aminotoluene; 6-Chloro-2-toluidine; 2-Methyl-6-chloroaniline; o-Toluidine, 6-chloro-; 2-Chloro-6-Methylaninile; 6-Chloro-o-toluidine (NH2=1); 2-methyl-6-chloro aniline; UNII-76F11RQ7TB; EINECS 201-759-2; NSC 60121; 2-chloro-6-methyl aniline; BRN 0774624; 2-chloro-6-methylbenzenamine; 2-chloro-6-methylphenylamine; 76F11RQ7TB; WFNLHDJJZSJARK-UHFFFAOYSA-N; MFCD00007679; 6-Chloro-o-toluidine [NH2=1]; 6-chloro-2-methyl aniline; NSC60121; PubChem22391; 6-Chlor-ortho-toluidin; 2-Amino-4-chluorotoluene; ACMC-209qp0; WLN: ZR BG F1; SCHEMBL94065; 6-chloro-2-methylbenzenamine; 2-chloranyl-6-methyl-aniline; 4-12-00-01789 (Beilstein Handbook Reference); KSC448A5B; 2-chloro-6-methyl-phenylamine; AMBZ0028; (2-Chloro-6-methylphenyl)amine; DTXSID8058956; CTK3E8050; 2-Chloro-6-methylaniline, 98%; Benzenamine, 6-chloro-2-methyl-; ZINC404327; ACN-S003620; CS-D1492; KS-000009QK; ANW-38866; GEO-00703; NSC-60121; SBB004153; STL164360; AKOS005254415; AC-4800; AS04751; AS06940; GS-3024; LS10715; MCULE-4849483236; RTC-060024; TRA0025418; AK-36668; Benzenamine, 6-chloro-2-methyl- (9CI); BP-13318; BR-36668; SC-15448; LS-154332; ST2409907; TC-060024; AM20060325; FT-0611875; ST50823752; 87C638; M-5472; A842321; W-200515; Q27266484; InChI=1/C7H8ClN/c1-5-3-2-4-6(8)7(5)9/h2-4H,9H2,1H; 2CM; 2-Chloro-6-methylaniline; 4-12-00-01789 (Beilstein Handbook Reference)
2-Hydroxy-1,2,3-propanetricarboxylic acid, Iron(3+) salt (1:1) Ferric citrate; Citric acid, iron(3+) salt (1:1)
2-Hydroxycinnamic acid (2E)-3-(2-Hydroxyphenyl)acrylic acid; 2-Hydroxycinnamic acid, (2E)-; 4-10-00-00999 (Beilstein Handbook Reference)
2-Hydroxyestradiol (17beta)-Estra-1,3,5(10)-triene-2,3,17-triol; 2-Hydroxyestradiol; 2-OH-Estradiol; 362-05-0; 2-hydroxy-estradiol; 2-OH-E2; 2-hydroxy-17beta-estradiol; 2-Hydroxyestradiol-17beta; (17beta)-Estra-1,3,5(10)-triene-2,3,17-triol; UNII-AYU2L67YUU; Estra-1,3,5(10)-triene-2,3,17beta-triol; CHEBI:28744; NSC 61711; AYU2L67YUU; 2-Hydroxy-17|A-estradiol; MLS000069506; CHEMBL467987; DILDHNKDVHLEQB-XSSYPUMDSA-N; ESTRA-1,3,5(10)-TRIENE-2,3,17-beta-TRIOL; SMR000058615; 1,3,5(10)-estratriene-2,3,17Beta-triol; 2,3,17beta-Trihydroxy-1,3,5(10)-Estratriene; ECS; BRN 2219367; CCRIS 8709; 2bw7; Opera_ID_1837; 17beta-2-Hydroxyestradiol; Epitope ID:159258; 4-06-00-07547 (Beilstein Handbook Reference); BIDD:ER0098; SCHEMBL225052; cid_247304; SGCUT00102; DTXSID3022372; HMS2230J22; HMS3648A04; NSC61711; to_000058; ZINC3815419; 1354AH; BDBM50262140; LMST02010027; MFCD00010490; NSC-61711; 2-Hydroxyestradiol, >=95% (HPLC); 2-Hydroxyestradiol, analytical standard; DB07706; NCGC00247034-01; CC-10980; Estra-1,3,5(10)-triene-2,3,17-triol; 1,3,5(10)-Estratriene-2,3-17beta-triol; Estra-1,3,5(10)-triene-2,3,17b-triol; 2,3,17b-Trihydroxyestra-1,3,5(10)-triene; C05301; Estra-1,3,5(10)-triene-2,3,17-triol #; Estra-1,5(10)-triene-2,3,17.beta.-triol; C-18139; Estra-1,3,5(10)-triene-2,3,17.beta.-triol; SR-01000946341; Estra-1,3,5 (10)-triene-2,3,17.beta.-triol; SR-01000946341-1; (17b)-Estra-1,3, 5(10)-triene-2,3,17-triol; Q27096924; Estra-1,3,5(10)-triene-2,3,17-triol, (17beta)-; Estra-1,5(10)-triene-2,3,17-triol, (17.beta.)-; (17beta)- Estra-1,3, 5 (10)-triene-2,3,17-triol; Estra-1,3,5(10)-triene-2,3,17-triol, (17.beta.)-; estra-1,3,5(10)-triene-2,3,17-triol (ACD/Name 4.0); (9beta,13alpha,14beta,17alpha)-estra-1,3,5(10)-triene-2,3,17-triol; (8R,9S,13S,14S,17S)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-2,3,17-triol; 2-Hydroxyestradiol; 4-06-00-07547 (Beilstein Handbook Reference)
2-Hydroxyquinoline 2(1H)-Quinolinone; 2-Hydroxyquinoline; 59-31-4; Quinolin-2-ol; 2-Quinolinol; Carbostyril; 2(1H)-Quinolinone; 2-Quinolone; Quinolin-2(1H)-one; Quinolinone; Quinolinol; alpha-Quinolone; 1H-quinolin-2-one; quinolone; o-Aminocinnamic acid lactam; 2-Quinolinone; 2(1H)-Quinolone; 104534-80-7; alpha-Hydroxyquinoline; 2-(1H)-QUINOLINONE; 70254-42-1; Hydroxyquinoleine [French]; UNII-803BHY7QWU; 1,2-dihydroquinolin-2-one; 1321-40-0; .alpha.-Quinolone; MFCD00006743; hydroquinolin-2-one; NSC 156783; CCRIS 4327; .alpha.-Hydroxyquinoline; EINECS 200-420-6; 2-Hydroxyquinoline, 98%; 803BHY7QWU; AI3-00782; CHEMBL186422; CHEBI:16365; LISFMEBWQUVKPJ-UHFFFAOYSA-N; 2-HYDROXYQUINOLINE (2-QUINOLINOL); 2-OXOQUINOLINE; Hydroxyquinoleine; hyroxyquinoline; hydroquinolinone; 1H-quinolinone; quino- lone; 1H-quinolone; 2-Chinolinol; quinolin-2-one; a-Hydroxyquinoline; 3srg; 1-H-quinolone; Carbostyril (VAN); EINECS 274-516-1; 2-[1h]-quinolone; ACMC-20aiyu; ACMC-1BPVD; 2-Quinolinol; Carbostyril; SCHEMBL8621; 2-oxo-1,2-dihydroquinoline; Carbostyril (VAN) (8CI); MLS004491723; NSC554; DTXSID1058769; CHEBI:18289; CTK0I1671; CTK0I4067; NSC-554; HMS3604N04; ACN-P000952; STR05548; ZINC8579298; ANW-33226; ANW-75508; BDBM50366034; CH-601; NSC156783; SBB004119; STK097666; STK414900; AKOS003297745; AKOS015897112; AC-3056; CS-W005598; DB04745; GS-6597; MCULE-5331233860; NSC-156783; PS-4021; RTR-037203; TRA0027401; KS-0000099J; NCGC00166019-01; AK100046; BP-10114; LS-52244; SMR003288680; ST075655; ST075656; SY003693; AB1001701; DB-021213; LS-142470; TR-037203; FT-0612637; ST24025137; EN300-67221; C06338; C06415; Z-5226; 10343-EP2272832A1; 10343-EP2281815A1; 10343-EP2289892A1; 10343-EP2292612A2; 10343-EP2301536A1; 10343-EP2301538A1; 10343-EP2305640A2; 10343-EP2305649A1; 10343-EP2305666A1; 10343-EP2311455A1; 10343-EP2314590A1; 10343-EP2316452A1; 33406-EP2277869A1; 33406-EP2287164A1; 33406-EP2298305A1; 33406-EP2301939A1; 33406-EP2308878A2; 33406-EP2311815A1; 33406-EP2380874A2; 059H314; 103227-EP2275409A1; 103227-EP2298774A1; 103227-EP2301921A1; 103227-EP2301926A1; 103227-EP2372804A1; 103227-EP2378585A1; AC-907/25014359; W-104563; Q27095480; Z57473020; F0001-1542; InChI=1/C9H7NO/c11-9-6-5-7-3-1-2-4-8(7)10-9/h1-6H,(H,10,11; 493-62-9; 2-Hydroxyquinoline; AI3-00782
2-Methyl-4-isothiazolin-3-one 2-Methyl-3(2H)-isothiazolone; 2-Methyl-4-isothiazolin-3-one; 2682-20-4; Methylisothiazolinone; 2-methylisothiazol-3(2h)-one; 2-Methyl-4-isothiazoline-3-one; 2-Methyl-3(2H)-isothiazolone; N-methylisothiazolone; 3(2H)-Isothiazolone, 2-methyl-; Caswell No. 572A; 2-methyl-3-isothiazolone; C4H5NOS; 2-methyl-1,2-thiazol-3(2H)-one; UNII-229D0E1QFA; N-Methyl-3-oxodihydroisothiazole; EINECS 220-239-6; 2-METHYL-2H-ISOTHIAZOL-3-ONE; 229D0E1QFA; 2-methyl-1,2-thiazol-3-one; 3(2H)-Isothiazolone, methyl-; CHEBI:53620; BEGLCMHJXHIJLR-UHFFFAOYSA-N; W-107150; 2-Methyl-4-isothiazolin-3-one, 50% aqueous solution; Neolone; Microcare MT; Kordek MLX; MIT (biocide); 125794-71-0; Acticide M 10; Acticide M 20; Bestcide 600; Kordek 50; Kordek 50C; Neolone 950; methyl-isothiazolinone; Kordek 573F; Kathon CG 243; n-methylisothiazolin-3-one; N-METHYL-3-OXODIHYDRO ISOTHIAZOLE; 243-K-Cg; HSDB 8200; MIT 950; MT 10; 2-Methyl-4-isothiazoline-3-ketone; KB 838; ACMC-1CJ8U; 2-methyl-4-isothiazolinone; DSSTox_CID_14259; DSSTox_GSID_34259; SCHEMBL17863; SCHEMBL113898; 2-methyl-3(2H)-isothiazoline; CHEMBL1620780; DTXSID2034259; CTK0F6815; 2-Methyl 4-Isothiazoline 3-one; 2-Methyl-3(2H)-isothiazolone #; ZINC1849933; Tox21_303814; ANW-56607; BBL104136; MFCD01742315; STL557951; 2-Methyl-4-isothiazolin-3-one (MI); AKOS007930246; AM84857; FCH1119869; RTR-012090; 2-Methyl-4-isothiazolin-3-one, 95%; KS-000018Y9; NCGC00357093-01; AK-25686; CC-11387; LS-86324; SC-16032; CAS-2682-20-4; AB0011560; AX8002292; DB-005250; TR-012090; FT-0601044; ST24022348; X5929; K-6885; 682M204; C-00606; Q423870; 2-Methyl-4-isothiazolin-3-one, analytical standard; 2-Methyl-4-isothiazolin-3-one 100 microg/mL in Methanol; UNII-15O9QS218W component BEGLCMHJXHIJLR-UHFFFAOYSA-N; 3(2H)-Isothiazolone, 2-methyl-; Caswell No. 572A
2-Naphthalenesulphonic acid 4-11-00-00527 (Beilstein Handbook Reference)
2-Thenoyltrifluoroacetone 4,4,4-Trifluoro-1-(2-thienyl)-1,3-butanedione; 2-Thenoyltrifluoroacetone; 326-91-0; THENOYLTRIFLUOROACETONE; 1,3-Butanedione, 4,4,4-trifluoro-1-(2-thienyl)-; 4,4,4-trifluoro-1-(thiophen-2-yl)butane-1,3-dione; Perfluoroacetyl(2-thenoyl)methane; alpha-Thenoyltrifluoroacetone; 1-Thenoyl-3,3,3-trifluoroacetone; 4,4,4-Trifluoro-1-(2-thienyl)-1,3-butanedione; 4,4,4-Trifluoro-1-(2-thienyl)butane-1,3-dione; 1,1,1-Trifluoro-3-(2-thenoyl)acetone; .alpha.-Thenoyltrifluoroacetone; UNII-MYQ9MNW7NI; NSC 66544; 1-(2-Thenoyl)-3,3,3-trifluoroacetone; 4,4,4-TRIFLUORO-1-THIEN-2-YLBUTANE-1,3-DIONE; MYQ9MNW7NI; EINECS 206-316-7; MFCD00005445; AI3-31295; TTB; CHEMBL1236433; TXBBUSUXYMIVOS-UHFFFAOYSA-N; Thenoyltrifluoroacetone, 99%; 29463-74-9; thenoyl trifluoroacetone; 2-thenoyl trifluoroacetone; ACMC-1CM3H; 2-thenoyl trifluoro acetone; 4,4,4-trifluoro-1-thiophen-2-ylbutane-1,3-dione; SCHEMBL195358; ARONIS021027; 1-Thenoyl-3,3-trifluoroacetone; 2-Thenoyltrifluoroacetone, 99%; DTXSID1059812; CTK0I4649; KS-00004CLY; TXBBUSUXYMIVOS-UHFFFAOYSA-; HMS3604B13; BCP21685; NSC66544; ANW-27410; BBL014250; BDBM50248361; HSCI1_000376; NSC-66544; SBB003341; STK020843; 1,1-Trifluoro-3-(2-thenoyl)acetone; AKOS000119762; ZINC100004957; AC-4921; CCG-207997; CS-W020091; DB04795; DS-1137; LS40311; MCULE-7481288995; PS-6790; RTR-013716; SC11823; TRA0096222; KS-00000C17; 1, 4,4,4-trifluoro-1-(2-thienyl)-; AK-46533; BR-46533; P634; SY004998; DB-001234; LS-166686; ST2410209; TR-013716; 1-(Thenoyl-(2'))-3,3,3-trifluoroacetone; AM20090477; EU-0000019; FT-0613433; ST45034729; 26T910; M-5475; 1,3-Butanedione, 4,4,4-trifluoro-1-(thienyl)-; 1-(2-thienyl)-4,4,4-trifluoro-1,3-butanedione; 2-Thenoyltrifluoroacetone, purum, >=97.0% (GC); 4,4,4-Trifluoro-1-(2-thienyl)-1,3-Butanedion; SR-01000388942; 1-(Thien-2-yl)-4,4,4-trifluorobutane-1,3-dione; 1-THIENYL-4,4,4-TRIFLUORO-1,3-BUTANEDIONE; Q-200324; Q5933755; SR-01000388942-1; 4,4,4-trifluoro-1-thiophen-2-yl-butane-1,3-dione; BRD-K00959089-001-01-4; Z57201518; F0346-3664; 2-Thenoyltrifluoroacetone pound>>4,4,4-trifluoro-1-(thiophen-2-yl)butane-1,3-dione; 2-Thenoyltrifluoroacetone, for spectrophotometric det. of metal ions, >=99.0%; InChI=1/C8H5F3O2S/c9-8(10,11)7(13)4-5(12)6-2-1-3-14-6/h1-3H,4H2; Thenoyltrifluoroacetone; AI3-31295
2-[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[5-(4,5-Dihydroxy-4,6-dimethyloxan-2-yl)oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde Spiramycin; spiramycin; 8025-81-8; ST075006; Prestwick_121; Prestwick2_000745; Prestwick3_000745; BPBio1_000804; SCHEMBL5032756; AKOS015896378; K430; SR-01000872632; SR-01000872632-1; Spiramycin, European Pharmacopoeia (EP) Reference Standard; Spiramycin from Streptomyces sp., VETRANAL(TM), analytical standard; Spiramycin, Pharmaceutical Secondary Standard; Certified Reference Material; 2-[(4R,5S,6S,7R,9R,10R,16R)-6-[4-(dimethylamino)-5-[4,6-dimethyl-4,5-bis(oxidanyl)oxan-2-yl]oxy-6-methyl-3-oxidanyl-oxan-2-yl]oxy-10-[5-(dimethylamino)-6-methyl-oxan-2-yl]oxy-5-methoxy-9,16-dimethyl-4-oxidanyl-2-oxidanylidene-1-oxacyclohexadeca-11,13-dien-7-yl]ethanal; 2-{(2S,3S,14S,1R,4R,8R,15R)-2-[5-(4,5-dihydroxy-4,6-dimethyl(2H-3,4,5,6-tetrah ydropyran-2-yl)oxy)-4-(dimethylamino)-3-hydroxy-6-methyl(2H-3,4,5,6-tetrahydro pyran-2-yl)oxy]-14-[5-(dimethylamino)-6-me; 2-{(2S,3S,14S,1R,4R,8R,15R)-2-[5-(4,5-dihydroxy-4,6-dimethyl(2H-3,4,5,6-tetrah ydropyran-2-yl)oxy)-4-(dimethylamino)-3-hydroxy-6-methyl(2H-3,4,5,6-tetrahydro pyran-2-yl)oxy]-14-[5-(dimethylamino)-6-methyl(2H-3,4,5,6-tetrahydropyran-2-yl )oxy]-4-hydroxy-3-; thyl(2H-3,4,5,6-tetrahydropyran-2-yl )oxy]-4-hydroxy-3-methoxy-8,15-dimethyl-6-oxo-7-oxacyclohexadeca-10,12-dienyl} ethanal; Spiramycin I; spiramycin; 24916-50-5; UNII-033ECH6IFG; 033ECH6IFG; 8025-81-8; NSC-55926; NSC-64393; CHEMBL453514; Leucomycin V, 9-O-((2R,5S,6R)-5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl)-; s5744; ZINC257373089; CS-8166; IL-5902; RP-5337; HY-100593; AB00514638; 025S818; Leucomycin V,9-O-[(2R,5S,6R)-5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl]-; [(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-{[(2S,3R,4R,5S,6R)-5-{[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-10-{[(2R,5S,6R)-5-(dimethylamino)-6-methyltetrahydro-2H-pyran-2-yl]oxy}-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxooxacyclohexadeca-11,13-dien-7-yl]acetaldehyde (non-preferred name); Leucomycin V, 9-O-(5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl)-, (9(2R,5S,6R))- (9CI); spiramycin; SR-05000001860; 8025-81-8; Spectrum5_001129; ex Streptomyces ambofaciens; BSPBio_003598; SPECTRUM1503423; HMS500A15; HMS1922C18; HMS2093G03; Pharmakon1600-01503423; CCG-38887; NSC758472; NSC-758472; IDI1_000013; AB00052356_02; JACS 91: 3401 (1969); SR-05000001860-1; SR-05000001860-2; BRD-K14716343-001-03-0; Foromacidine A; Spiramycin A; Spiramycin 1; Spiramycin I; Demycarosylturimycin H; spiramycin; Foromacidin; Foromacidin A; C43H74N2O14; UNII-033ECH6IFG; 033ECH6IFG; 24916-50-5; 8025-81-8; NSC55926; Rovamycinetrade mark; NSC64393; IC 5902; CHEBI:85260; Leucomycin V, 9-O-((2R,5S,6R)-5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl)-; DB06145; LS-145761; J-015730; UNII-71ODY0V87H component ACTOXUHEUCPTEW-KWBWCIJSSA-N; Leucomycin V, 9-O-(5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl)-, (9(2R,5S,6R))-; [(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-{[(2S,3R,4R,5S,6R)-5-{[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy}-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-10-{[(2R,5S,6S)-5-(dimethylamino)-6-methyloxan-2-yl]oxy}-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde; 2-[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[(2S,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-10-[(2R,5S,6S)-5-(dimethylamino)-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde; Spiramycin I; spiramycin; spiramycin (undefined stereochemistry); 24916-50-5; 8025-81-8; BCP31237; Q13023033; 2-[6-({5-[(4,5-dihydroxy-4,6-dimethyloxan-2-yl)oxy]-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl}oxy)-10-{[5-(dimethylamino)-6-methyloxan-2-yl]oxy}-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde; spiramycin; Spiramycin I; Foromacidin; Foromacidin A; NSC55926; NSC-55926; ACTOXUHEUCPTEW-OBURPCBNSA-N; Leucomycin V, 9-O-[(2R,5S,6R)-5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl]-; STL455016; Q422265; [(11E,13E)-6-({5-[(4,5-dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl}oxy)-10-{[5-(dimethylamino)-6-methyltetrahydro-2H-pyran-2-yl]oxy; spiramycin; Formacidine; 8025-81-8; s4082; ZINC252441616; NCGC00386279-01; AB01566928_01; spiramycin; 8025-81-8; spiramycin; Formacidine; 8025-81-8; S0575; spiramycin; 8025-81-8; AK00617947; Spiramycin I; spiramycin; 24916-50-5; NCGC00016687-01; CAS-8025-81-8; DSSTox_CID_3594; DSSTox_RID_80855; DSSTox_GSID_45402; SCHEMBL432512; CHEMBL1255799; DTXSID9023594; Leucomycin V, 9-O-((2R,5S,6R)-5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl)-; 8025-81-8; Tox21_110562; ZINC257373088; spiramycin; BDBM50248188; spiramycin; spiramycin; 8025-81-8; spiramycin; 8025-81-8; spiramycin; 8025-81-8; spiramycin; 8025-81-8; spiramycin; SW219603-1; RP 5337
2-[8-[4-Acetyloxy-3,5-dihydroxy-6-(2-methylbut-3-en-2-yloxymethyl)oxan-2-yl]oxy-4,9-dihydroxy-14-(methoxymethyl)-3,10-dimethyl-6-tricyclo[9.3.0.03,7]tetradeca-1,6-dienyl]propyl acetate (1S,4R,5R,6R,6aS,9S,10aR)-3-[(1S)-2-(Acetyloxy)-1-methylethyl]-1,2,4,5,6,6a,7,8,9,10a-decahydro-1,5-dihydroxy-9-(methoxymethyl)-6,10a-dimethyldicyclopenta[a,d]cycloocten-4-yl 6-O-(1,1-dimethyl-2-propen-1-yl)-alpha-D-glucopyranoside 3-acetate; Fusicoccin; Fucicoccin
25-Hydroxycholesterol (3beta)-Cholest-5-ene-3,25-diol; 25-Hydroxycholesterol; 2140-46-7; 5-Cholestene-3beta,25-diol; Cholest-5-ene-3beta,25-diol; 25-hydroxy-cholesterol; 25-OHC; cholest-5-en-3beta,25-diol; UNII-767JTD2N31; CHEBI:42977; INBGSXNNRGWLJU-ZHHJOTBYSA-N; 767JTD2N31; NCGC00181327-01; 25-hydroxy cholesterol; (3S,8S,9S,10R,13R,14S,17R)-17-[(1R)-5-hydroxy-1,5-dimethyl-hexyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; HC3; 25-Hydroxycholest-5-en-3-ol; 5-cholesten-3beta,25-diol; MFCD00057815; (8S,9S,10R,13R,14S,17R)-17-((R)-6-Hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol; Cholest-5-ene-3,25-diol, (3b)-; (3BETA)-CHOLEST-5-ENE-3,25-DIOL; DSSTox_CID_24023; DSSTox_RID_80099; DSSTox_GSID_44023; SCHEMBL177267; Cholest-5-ene-3?,25-diol; CHEMBL169046; GTPL2885; DTXSID5044023; 25-Hydroxycholesterol, >=98%; BDBM20182; CTK4E6668; ZINC5751264; Tox21_112790; (3?)-Cholest-5-ene-3,25-diol; LMST01010018; DB04705; (3S,8S,9S,10R,13R,14S,17R)-17-[(2R)-6-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; AS-57475; CAS-2140-46-7; HY-113134; CS-0061533; C15519; 140H467; C-46012; (3beta,14beta,17alpha)-cholest-5-ene-3,25-diol; W-201876; Q27071875; Bicyclo[4.1.0]heptane-3,4-diol,3,7,7-trimethyl-, (1S,3S,4S,6R)-; (1S,2R,5S,10S,11S,14R,15R)-14-[(2R)-6-hydroxy-6-methylheptan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0; {2,7}.0; {11,15}]heptadec-7-en-5-ol; (3S,8S,9S,10R,13R,14S,17R)-17-((R)-6-hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol; 25-Hydroxycholesterol; 5-Cholestene-3beta,25-diol
3,4-Dihydroxyphenylacetic acid 3,4-Dihydroxybenzeneacetic acid; 3,4-Dihydroxyphenylacetic acid; 4-10-00-01509 (Beilstein Handbook Reference)
3,4-Dimethylaniline 3,4-Dimethylbenzenamine; 3,4-Dimethylaniline; 95-64-7; 3,4-XYLIDINE; 4-Amino-o-xylene; 3,4-Xylylamine; Benzenamine, 3,4-dimethyl-; 3,4-Dimethylphenylamine; 3,4-Dimethylbenzenamine; 3,4-Dimethylaminobenzene; 1-Amino-3,4-dimethylbenzene; 4-Amino-1,2-dimethylbenzene; Aniline, 3,4-dimethyl; 3,4-Dimethylbenzeneamine; UNII-R27I33AIDT; NSC 41800; 3,4-dimethylbenzene-1-amine; CCRIS 4741; HSDB 2095; Benzene, 4-amino-1,2-dimethyl-; EINECS 202-437-4; BRN 0507414; R27I33AIDT; AI3-22779; DTXSID3026308; CHEBI:39901; DOLQYFPDPKPQSS-UHFFFAOYSA-N; Benzenamine,4-dimethyl-; WLN: ZR C1 D1; 3,4-Dimethylaniline, 99.5%; 3,4-dimetylaniline; 3,4-dimethyl aniline; ACMC-1BAUS; 3,4-dimethyl-phenylamine; Aniline, 3,4-dimethyl-; DSSTox_CID_6308; (3,4-dimethylphenyl)amine; EC 202-437-4; DSSTox_RID_78098; DSSTox_GSID_26308; SCHEMBL33278; 3,4-Dimethylaniline, 98%; 4-12-00-02502 (Beilstein Handbook Reference); KSC493Q7H; MLS002302996; BIDD:GT0847; (3,4-dimethyl-phenyl)-amine; TPC-I109; CHEMBL1230039; CTK3J3873; KS-00000WHP; NSC7099; HMS3039N06; NSC-7099; NSC41800; STR00577; ZINC3860992; Tox21_200058; ANW-40543; MFCD00007810; NSC-41800; SBB040496; STL169144; AKOS000119113; AS07069; DB03018; LS-1983; MCULE-3181938394; NE10515; PS-4095; RTR-038565; TRA0081309; CAS-95-64-7; NCGC00091393-01; NCGC00091393-02; NCGC00257612-01; 34A; AC-10833; K728; SMR001307311; AB1000591; DB-021935; ST2404598; TR-038565; D0670; FT-0614365; ST45255272; AZ0001-0113; 3-ethyl-4-hydroxy-pyrido[1,2-a]pyrimidin-2-one; Q4634078; W-100161; 3506D145-E251-4BEA-B1C2-57DE580CBCA1; F2190-0465; Z1245633942; UNII-0V872Q19HT component DOLQYFPDPKPQSS-UHFFFAOYSA-N; 3,4-Xylidine; 4-Amino-1,2-dimethylbenzene; 4-Amino-o-xylene; InChI=1/C8H11N/c1-6-3-4-8(9)5-7(6)2/h3-5H,9H2,1-2H; 3,4-Xylidine; 4-12-00-02502 (Beilstein Handbook Reference)
3,4-Dimethylphenol 3,4-DIMETHYLPHENOL; 95-65-8; 3,4-Xylenol; Phenol, 3,4-dimethyl-; 4,5-Dimethylphenol; 1,3,4-Xylenol; 3,4-Dimethyl phenol; 1-Hydroxy-3,4-dimethylbenzene; 4-Hydroxy-1,2-dimethylbenzene; 3,4-DMP; 3,4-dimethyl-phenol; NSC 1549; CCRIS 723; UNII-4L479F5JU6; FEMA No. 3596; 1,2-Dimethyl-4-hydroxybenzene; HSDB 5294; EINECS 202-439-5; BRN 1099267; AI3-01552; CHEBI:39839; YCOXTKKNXUZSKD-UHFFFAOYSA-N; 4L479F5JU6; DSSTox_CID_4062; DSSTox_RID_77274; DSSTox_GSID_24062; 3,4-Dimethylphenol, 99%; CAS-95-65-8; 2MP; Asym-O-Xylenol; 4-Hydroxy-o-xylene; 1,4-Xylenol; 3, 4-Xylenol; 3,4--Xylenol; 1,2,4-Xylenol; PubChem21761; ACMC-209rzo; 3,4-Xylenol, 8CI; 3,4-Dimethylphenol (1); EC 202-439-5; 3,4-Dimethylphenol, 98%; 4-06-00-03099 (Beilstein Handbook Reference); KSC490K4L; SCHEMBL125704; WLN: QR C1 D1; CHEMBL192008; DTXSID4024062; 1-Hydroxy-3, 4-dimethylbenzene; CTK3J0545; FEMA 3596; NSC1549; BDBM238309; 3,4-Xylenol, >=98%, FG; NSC-1549; STR06236; ZINC1576886; Tox21_201523; Tox21_300185; ANW-40546; LS-286; MFCD00002304; SBB060427; STL570694; AKOS000119349; DB04052; MCULE-1568356481; NE10167; RTR-029823; KS-0000009R; NCGC00091845-01; NCGC00091845-02; NCGC00091845-03; NCGC00253983-01; NCGC00259073-01; AC-10834; SC-18062; DB-003356; ST2417254; TR-029823; D0777; FT-0614380; ST51046607; 3,4-Dimethylphenol 100 microg/mL in Methanol; Q-200346; Q4634081; 3,4-Dimethylphenol, PESTANAL(R), analytical standard; F0001-2276; Z955123648; UNII-I4C43Y9C7V component YCOXTKKNXUZSKD-UHFFFAOYSA-N; InChI=1/C8H10O/c1-6-3-4-8(9)5-7(6)2/h3-5,9H,1-2H; 4-06-00-03099 (Beilstein Handbook Reference)
3,5-Diiodo-L-tyrosine 3,5-Diiodo-L-tyrosine; 300-39-0; Diiodotyrosine; L-3,5-Diiodotyrosine; 3,5-DIIODOTYROSINE; L-Diiodotyrosine; H-Tyr(3,5-I2)-OH; (S)-2-Amino-3-(4-hydroxy-3,5-diiodophenyl)propanoic acid; 3,5-L-Diiodotyrosine; 3,5-Iodo-L-tyrosine; Tyrosine, 3,5-diiodo-; DIT (amino acid); L-Tyrosine, 3,5-diiodo-; (2S)-2-amino-3-(4-hydroxy-3,5-diiodophenyl)propanoic acid; DiIY; UNII-6L57Q44ZWW; 3,5-Diiodotyrocine; CHEBI:15768; NSC 4143; 6L57Q44ZWW; NYPYHUZRZVSYKL-ZETCQYMHSA-N; NCGC00163111-01; H-3,5-Diiodo-Tyr-OH; 3,5-Diiodo-tyrosine; DSSTox_CID_28606; DSSTox_RID_82876; DSSTox_GSID_48680; J-300288; J-300435; CAS-300-39-0; DIOTYROSINE; Dijodtyrosin; DIT; EINECS 206-092-0; MFCD00016542; PubChem11976; 3,5-Diiodo-4-Hydroxy-beta-Phenylalanine; Spectrum5_001996; bmse000327; Epitope ID:122959; KSC223E8J; MLS000028503; SCHEMBL147579; GTPL6651; H-Tyr(3,5-Di-I)-OH; Tyrosine, 3,5-diiodo-, L-; CHEMBL1236469; DTXSID0048680; CTK1C3284; TRYOSINE, 3,5-DIIODO-; HMS2230P17; 4-Hydroxy-3,5-diiodophenylalanine; ACT02978; ZINC3861723; Tox21_113061; 8172AF; ANW-47545; CD-344; STL570262; AKOS002276212; Tox21_113061_1; AM83562; DB03374; EBD2157962; MCULE-2428039618; RTR-012966; KS-0000102L; Tyrosine, 3,5-diiodo-, L- (8CI); NCGC00163111-02; AK-25733; BR-25733; CC-13571; SC-09976; SMR000058274; AX8007742; DB-022066; TR-012966; D0612; FT-0614629; ST50186943; 3,5-Diiodo-L-tyrosine dihydrate, crystalline; C01060; 300D390; C-22275; Q410521; UNII-ST90Q60YF3 component NYPYHUZRZVSYKL-ZETCQYMHSA-N; (2S)-2-amino-3-(4-hydroxy-3,5-diiodo-phenyl)propanoic acid; E33DC826-4246-4751-B348-4B31BFB6F996; TYI; Diiodotyrosine; 3,5-L-Diiodotyrosine
3,5-Diiodosalicylic acid 3,5-Diiodo-2-hydroxybenzoic acid; 3,5-Diiodosalicylic acid; 4-27-00-07537 (Beilstein Handbook Reference)
3,5-Diiodothyropropionic acid 4-(4-Hydroxyphenoxy)-3,5-diiodobenzenepropanoic acid; 3,5-Diiodothyropropionic acid; 3,5-Ditpa
3,6-Diamino-10-methylacridinium, Chloride (1:1) 3,6-Diamino-10-methylacridinium chloride; C.I. 46000